Introduction {#S1}
============

Human leukocyte antigen G (*HLA-G*) belongs to the family of non-classical HLA class I genes, located within the major histocompatibility complex (MHC) at chromosomal region 6p21.3. The MHC segment is considered to be the most polymorphic region in vertebrate genome ([@B1]). Although the *HLA-G* product presents the same class I classical molecule structure, its main function is not antigen presentation. HLA-G function in the immune response regulation has been extensively studied since its discovery by Geraghty and colleagues in 1987 ([@B2]).

The *HLA-G* gene has been the target of most recent research regarding the function of class I non-classical genes. The main features that distinguish *HLA-G* from classical class I genes are (a) limited protein variability, (b) alternative splicing generating several membrane bound and soluble isoforms, (c) short cytoplasmic tail, (d) modulation of immune response (immune tolerance), and (e) restricted expression to certain tissues ([@B3]).

The HLA-G molecule does not seem to stimulate immune responses, however, it exerts inhibitory functions against natural killer (NK) cells ([@B4]), T lymphocytes ([@B4]), and antigen-presenting cells (APC) ([@B5]) through direct interaction with multiple inhibitory receptors such as ILT2/CD85j/LILRB1 (ILT2), expressed by all monocytes, B cells, some lineages of T cells, and NK cells ([@B6]); ILT4/CD85d/LILRB2 (ILT4), only expressed by monocytes and dendritic cells ([@B7]); and KIR2DL4/CD158d (KIR2DL4) that has a restricted expression to CD56 NK cells ([@B8]).

HLA-G role in immune tolerance was first studied in trophoblast cells at the maternal--fetal interface ([@B9]). Several studies reported an aberrant or reduced HLA-G expression in both mRNA and protein levels. This phenomenon was observed in pathological conditions such as preeclampsia ([@B10]) and recurrent spontaneous abortion ([@B11]) in comparison with normal placentas.

Beyond trophoblast expression, HLA-G is related to a variety of physiological and pathological conditions. In physiological conditions, HLA-G expression has been documented in cornea ([@B12]), thymus ([@B13]), and erythroid and endothelial precursors ([@B14]). On the other hand, HLA-G variation sites and/or expression levels are associated with pathological conditions such as viral infections ([@B15]--[@B20]), cancer ([@B21]--[@B27]), recurrent miscarriage ([@B28]--[@B37]), pregnancy outcome and pregnancy complications ([@B37]--[@B45]), autoimmune diseases ([@B46]--[@B54]), transplantation outcome ([@B55]--[@B57]), and inflammatory diseases ([@B58]--[@B61]), indicating that *HLA-G* encodes a critical molecule for the immune system.

*HLA-G* Genetic Structure {#S2}
=========================

The *HLA-G* gene presents a structure that resembles other classical class I genes such as *HLA-A, HLA-B*, and *HLA-C*. *HLA-G* encodes for a membrane-bound molecule with the same extracellular domains presented by other class I molecules, including the association with the β2-microglobulin. However, its main function is not antigen presentation.

The *HLA-G* gene exon/intron structure and splicing patterns are well defined, but there are inconsistencies between the National Center for Biotechnology Information (NCBI)[^1^](#fn1){ref-type="fn"}, the International Immunogenetics Database (IMGT/HLA[^2^](#fn2){ref-type="fn"}), and the Ensembl database[^3^](#fn3){ref-type="fn"} annotations regarding its structure, mainly because the IMGT/HLA database only presents sequences within 300 bases upstream the coding sequence (CDS) and the database does not consider most of the 3′ untranslated region (UTR) segment. Therefore, in the present work, the structure defined by NCBI/Ensembl will be used throughout the text.

According to the NCBI reference sequence NC_000006.12 (GRCh38 or hg19) and transcripts such as NM_002127.5 (NCBI), ENST00000428701, and ENST00000376828 (Ensembl), the *HLA-G* gene (NCBI Gene ID: 3135) presents eight exons and seven introns, consistent with a classical class I gene structure, and encompasses a region of 4144 nucleotides between positions 29826979 and 29831122 at 6p21.3 (GRCh38). This gene is surrounded by some of the most polymorphic genes in the human genome (Figure [1](#F1){ref-type="fig"}), such as *HLA-A* (115 Kb downstream)*, HLA-B* (1526 Kb downstream), and *HLA-C* (1441 Kb downstream), and other non-classical HLA loci such as *HLA-E* (662 Kb downstream) and *HLA-F* (103 Kb upstream). According to the NCBI annotation and hg19, the *HLA-G* DNA segment encodes a full-length mRNA of 1578 nucleotides and alternative smaller ones, as discussed later. Considering the full-length mRNA, 1017 nucleotides represent the CDS encoding for a full-length protein of 338 amino acids, 178 nucleotides represent the 5′UTR segment, and 383 nucleotides represent the 3′UTR segment.

![***HLA-G* gene structure and transcripts**.](fimmu-05-00476-g001){#F1}

There is no consensus regarding the exact location where the *HLA-G* transcription may start. Considering the NCBI and Ensembl annotations, and the transcripts NM_002127.5 from NCBI and ENST00000428701 from Ensembl, the *HLA-G* transcription starts 866 nucleotides upstream the initial translated ATG (third \* at Figure [1](#F1){ref-type="fig"}). However, other transcripts tell us a different story: ENST00000376828 indicates that the *HLA-G* transcription might start even earlier, while ENST00000360323 indicates that the transcription starts 24 nucleotides upstream the initial translated ATG. Given these contradictory information, it is possible that the *HLA-G* gene presents multiple transcription start points depending on the presence of specific transcription factors or other expression inducing mechanisms, but it probably presents only one translation start point as described further. Since there is no consensus, in the present work, we opt to use the annotation presented by both NCBI and Ensembl, considering NM_002127.5 and ENST00000428701 as references. Considering the transcription start site indicated by NM_002127.5/ENST00000428701 or ENST00000360323, *HLA-G* presents a large 5′UTR segment. Within this segment, there is an intron (intron 1) of about 688 nucleotides that is spliced out, giving rise to 5′UTR of about 178 nucleotides composed of DNA segments of two adjacent exons. Considering this transcription start point, the *HLA-G* 5′ sequence presents at least three potential translation start points, i.e., two in the 5′UTR and the third one defining the beginning of the CDS. In the present work, we will consider the Adenine of this third ATG, i.e., the first base of the CDS, as nucleotide +1. Although conventional nomenclature would suggest the first transcribed base as nucleotide +1, our decision will avoid unnecessary confusion regarding the position of various well-established *HLA-G* variation sites. All nucleotides before the CDS will be noted as negative numbers and nucleotides in the CDS segment will be noted as positive numbers, using as a reference sequence the one available at the official human genome hg19 or NC_000006.12.

The first ATG is found between nucleotides −154 and −152 (mRNA) or nucleotides −842 and −840 (DNA). The second one is found between nucleotides −118 and −116 (mRNA) or nucleotides −806 and −804 (DNA). Both of these translation start points are in the same frame and are included in a sequence that does not resemble the preferred translation initiation sequence (Kozak consensus sequence) and might not initiate translation ([@B62]). Even if the first ATG is used, it would produce a peptide of only eight residues due to a stop codon found downstream in the reading frame. Alternatively, if the second ATG is used, a protein of about 136 amino acid residues would be produced. Although in a different frame from the main translation start point (the third one), this 136 amino acid molecule is quite similar to other human and primate class I molecule alpha-1 domains. The third and main ATG is compatible with the preferred Kozac sequence ([@B62]) and it initiates the translation of the full-length 338 amino acid residues protein and defines the beginning of the CDS segment.

The *HLA-G* CDS is composed of joining segments of six exons, in which the first contains the translation start point and the last one contains the stop codon (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). It should be noted that there is no consensus regarding exon and intron nomenclature between NCBI/Ensembl and the IMGT/HLA databases. IMGT/HLA considers as exon 1 the first mRNA segment that is translated, i.e., exon 2 for NCBI/Ensembl (Figure [1](#F1){ref-type="fig"}). The actual exon 2, which encodes the final portion of the 5′UTR, contains the main translation start point and in fact encodes the HLA-G leader peptide (Figure [1](#F1){ref-type="fig"}). In addition, exons 3, 4, and 5 encode the alpha-1, alpha-2, and alpha-3 domains, respectively, exon 6 encodes the transmembrane domain, and exon 7 the cytoplasmic tail. A premature stop codon at exon 7 leads to a shorter cytoplasmic tail when compared to other class I molecules (Figure [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}). The segment downstream the stop codon at exon 7 extending to exon 8 composes the *HLA-G* 3′UTR. The *HLA-G* mRNA 3′UTR is short when compared to other class I genes. This gene structure description highlights one of the widely spread misconceptions regarding *HLA-G* gene structure: in 1987, Geraghty and colleagues proposed the existence of an exon 7 based on homology with classical class I genes ([@B2]). This "exon 7" was in fact part of the intron 7 (NCBI) and it is usually absent in most of the *HLA-G* transcripts. Although this "exon 7" segment has been found in alternative transcripts (e.g., ENST00000478519), other intron segments are also sometimes kept in rare alternative transcripts (e.g., ENST00000478355), since alternative splicing is an important characteristic of the *HLA-G* gene as described further.

###### 

**The *HLA-G* exons and introns, their size, function, and nomenclature**.

  According to NC_000006.12 (hg19)   According to IMGT/HLA   Size (nt)   Function considering the full-length mRNA
  ---------------------------------- ----------------------- ----------- -------------------------------------------
  Exon 1                             --                      66          5′UTR
  Intron 1                           --                      688         Spliced out
  Exon 2                             Exon 1                  185         5′UTR/Leader peptide
  Intron 2                           Intron 1                129         Spliced out
  Exon 3                             Exon 2                  270         Alpha-1 domain
  Intron 3                           Intron 2                226         Spliced out
  Exon 4                             Exon 3                  276         Alpha-2 domain
  Intron 4                           Intron 3                599         Spliced out
  Exon 5                             Exon 4                  276         Alpha-3 domain
  Intron 5                           Intron 4                122         Spliced out
  Exon 6                             Exon 5                  117         Transmembrane domain/cytoplasmic tail
  Intron 6                           Intron 5                445         Spliced out
  Exon 7                             Exon 6                  33          Cytoplasmic tail/stop codon/3′UTR
  Intron 7                           --                      357         Spliced out
  Exon 8                             --                      355         3′UTR

The *HLA-G* gene may produce at least seven protein isoforms generated by alternative splicing of the primary transcript (Figure [1](#F1){ref-type="fig"}). Four isoforms are membrane bound presenting the transmembrane domain and the short cytoplasmic tail. HLA-G1 is the full-length membrane-bound isoform with a structure that resembles classical class I molecules. HLA-G2 lacks alpha-2 domain, HLA-G3 lacks alpha-2 and alpha-3 domains, and HLA-G4 lacks alpha-3 domain. Three isoforms are soluble due to the lack of the transmembrane domain. The soluble HLA-G5 and HLA-G6 isoforms present the same extracellular domains of HLA-G1 and HLA-G2, respectively; however, both transcript variants retain intron 5 leading to a stop codon before the translation of the transmembrane domain, and a tail of 21 amino acids implicated in their solubility. HLA-G7 transcript variant retains intron 3 leading to a premature stop codon. Therefore, HLA-G7 isoform presents only the alpha-1 domain linked to two amino acids encoded by intron 2 (Figure [1](#F1){ref-type="fig"}) ([@B63]--[@B65]).

In the next sections, we will address the *HLA-G* variability and haplotype diversity among several populations around the world.

*HLA-G* Variability as Described in the 1000Genomes Project {#S3}
===========================================================

The 1000Genomes Project is a large survey aiming to sequence the entire genome of thousands of individuals in several populations around the world ([@B66]). In the initial released data, the phased genotypes of 1092 individuals from 14 populations were available. These data have driven several studies regarding *HLA-G* variability and evolutionary aspects ([@B67]--[@B69]).

The initial genotype published by the 1000Genomes Project was based on exome sequencing or whole genome low coverage sequencing and lacks several known *HLA-G* polymorphisms due to limitations in the genotype detection procedures at that moment. Among the missing polymorphic sites, we may highlight some known indels, such as the traditionally studied 14-bp presence or absence (insertion/deletion) in the *HLA-G* 3′UTR. In addition, the method used to infer genotypes and haplotypes failed to clearly distinguish triallelic SNPs, reporting them as biallelic ones (e.g., the *HLA-G* promoter SNP at position −725C/T/G, rs1233334).

Considering these technical limitations and considering the fact that most of the bioinformatics tools used in the initial survey are now more advanced and developed, we have reevaluated the 1000Genomes raw sequencing data regarding the *HLA-G* gene using a locally developed pipeline to get genotypes and haplotypes, to better understand the *HLA-G* variability around the world and to retrieve data regarding some *HLA-G* missed polymorphic sites.

First, by using Samtools ([@B70]) subroutine view, we downloaded the BAM files (binary alignment map) containing the 1000Genomes official alignment data for the *HLA-G* gene region (between positions 29793317 and 29799834 at chromosome 6) directly from the 1000Genomes server (<ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/>). The reads downloaded were already trimmed on both ends for primer sequences. The download was performed for each of the initial 1092 samples and included data from both low coverage whole genome and exome when available. It should be mentioned that we got the sequences (reads) from BAM files representing the *HLA-G* region, thus, the next step of our pipeline used only the reads that were previously mapped to the *HLA-G* region by the 1000Genomes Consortium. Each BAM file was converted into a Fastq format file retrieving all reads that were previously mapped to the *HLA-G* region. The BAM to Fastq conversion was made using Bamtools (<https://github.com/pezmaster31/bamtools/>) and Perl scripts (locally developed) to filter out duplicated reads and to classify the reads as paired or unpaired.

Both paired and unpaired Fastq files were mapped to a masked chromosome 6 (hg19), in which only the *HLA-G* region was available and the rest of the chromosome was masked with "N" to preserve nucleotide positions regarding hg19. To date, hg19 presents a *HLA-G* coding region sequence compatible with the widely spread *HLA-G* allele known as G\*01:01:01:05. Mapping was performed using the application BWA, subroutine ALN ([@B71]), configured to allow the extension of a deletion up to 20 nucleotides, in order to evaluate the 14-bp polymorphism. The resulting BAM files from the newly mapped reads, from both paired-end and unpaired sequences, were joined using Picard-tools (<http://picard.sourceforge.net/index.shtml>). Regions containing indels were locally realigned by using the application GATK ([@B72]), routines RealignerTargetCreator and IndelRealigner. This local realignment used as reference a file containing known *HLA-G* indels. The Bamtools software was also used to remove reads mapped with low mapping quality (MQ) scores (MQ \< 40). After the procedure described above, 16 samples were discarded because all mapped reads (or most of them) were withdrawn due to poor MQ scores. The GATK routine UnifiedGenotyper was used to infer genotypes and a VCF file (variant call format) was generated.

Given the low coverage nature of the 1000Genomes data, some genotypes called by GATK are far uncertain, mainly in situations in which a homozygous genotype is inferred when that position presents low depth coverage. In addition, given the polymorphic nature and the high level of sequence similarity of HLA genes, some level of miss-mapped reads is expected and might bias genotype inference. To circumvent this issue, the VCF file generated by GATK was treated with a locally developed Perl script that applied the rules described below. This script uses the number of different reads detected for each allele at a given position (provided by GATK when the VCF file was generated).

-- Homozygosity was only inferred when a minimal coverage of seven reads was achieved; otherwise, a missing allele was introduced in this genotype. This procedure assures (*p* \> 0.99) that a homozygous genotype is called because of lack of variance at that position and not because the second allele was not sampled.-- Genotypes, in which one allele was extremely underrepresented (proportion of reads under 5%), were considered as homozygous for the most represented allele. This procedure minimizes the influence of miss-mapped reads to the *HLA-G* region and the high level of sequencing errors that characterizes next-generation sequencing data, and such correction was applied only in situations characterized by high depth of coverage (20 or more reads available for the evaluated position).-- For genotypes in which one allele was mildly underrepresented (with a proportion of reads between 5 and 20%), a missing allele was introduced representing this underrepresented allele. This procedure is particularly helpful in situations characterized by low depth of coverage (less than 20 reads available for the evaluated position), in which a single read may indicate the existence of an alternative allele, such read may be a miss-mapped read (false positive variant) or may represent a true unbalanced heterozygous genotype (true positive variant). Therefore, the definitive status of this kind of genotype (homozygous or heterozygous) was inferred during a final imputation step.-- Genotypes in which the proportion of reads for the less represented allele was higher than 20% were considered to be heterozygous. This procedure assures that only high-quality heterozygous genotypes are passed forward to the imputation procedure.

After applying the rules described above, the *HLA-G* database presented 8.42% of missing alleles, i.e., alleles that were considered uncertain because of low coverage or bad proportions. Some single nucleotide variations (SNVs) previously detected (with low quality) were converted into monomorphic as the alternative allele was removed or coded as missing, thus, they were not considered for further analyses. By using the VCFtools package ([@B73]), we removed SNVs that were no longer variable or that were represented just once in the dataset (i.e., singletons). In addition, we predicted the functional effect of each SNV, i.e., they were classified as coding synonymous mutations, coding non-synonymous mutations, splice site acceptors, stop-codon generation, and others, by using Snpeff ([@B74]). The missing alleles were imputed as well as *HLA-G* haplotypes were inferred by using the PHASE algorithm ([@B75]) as previously described ([@B76], [@B77]). For this purpose, a database containing high-quality genotype information for 133 SNVs for each of the 1076 remaining samples was used. The haplotyping procedure generated 200 haplotypes, with a mean haplotype pair probability of 0.7965 and with 524 samples (48.70%) presenting a haplotype pair with a probability higher than 0.9. The results of the procedure described above were presented separately for each *HLA-G* region (coding, 3′UTR and promoter) and, finally, as fully characterized extended haplotypes.

To characterize and explore global patterns of *HLA-G* diversity, a population genetics approach was performed using the ARLEQUIN 3.5.1.3 software ([@B78], [@B79]). The frequencies of each *HLA-G* haplotype were computed by the direct counting method and adherences of diplotype proportions to expectations under Hardy--Weinberg equilibrium were tested by the exact test of Guo and Thompson ([@B80]). Intrapopulational genetic diversity parameters were assessed in each population by computation of gene diversity (average expected heterozygosity across variation sites), haplotype diversity, nucleotide diversity, and the number of private haplotypes. Interpopulation genetic diversity was explored by means of pair-wise *F~ST~* estimates ([@B81]), by the exact test of population differentiation ([@B82]), and by the analysis of molecular variance (AMOVA) ([@B83]), all based on haplotype frequencies. Since the pair-wise *F~ST~* and the exact test of population differentiation between pairs of populations represent 91 statistical comparisons, the Bonferroni correction was used to adjust the significance level for multiple testing, resulting in a α = 0.0005 (i.e., 0.05/91). Reynolds' genetics distance was also estimated for each pair of population samples by the ARLEQUIN 3.5.1.3 software ([@B78], [@B79], [@B84]). The resulting matrix was used to generate a multidimensional scaling (MDS) using the PASW Statistics (17.0.2) software (SPSS Inc.).

*HLA-G* Coding Region Variability and Haplotypes {#S4}
================================================

In contrast to classical *HLA* class I genes, *HLA-G* presents low variability in its coding region. To date, only 50 coding alleles or haplotypes are officially recognized by the IMGT/HLA database[^2^](#fn2){ref-type="fn"} (version 3.17.0.1). Most of the SNVs in the *HLA-G* coding region are either coding synonymous mutations or intronic variants. Therefore, these 50 officially recognized *HLA-G* alleles encode only 16 different full-length proteins and two truncated molecules (null alleles). This is a distinctive feature of the *HLA-G* gene and also of other non-classical class I genes: only 36% of the known *HLA-G* alleles are associated with different HLA-G molecules when compared to classical class I genes, in which 75.4% for *HLA-A*, 77.8% for *HLA-B*, and 73.5% for *HLA-C* alleles are associated with different molecules (IMGT/HLA). The limited *HLA-G* coding region polymorphism is distributed among the alpha-1, alpha-2, and alpha-3 domains, while for classical class I genes, polymorphisms are found mainly around the region encoding the peptide binding groove, i.e., alpha-1 and alpha-2 domains ([@B1]). This is particularly evident for *HLA-B*, in which there is at least one recognized allele carrying a mutation for each nucleotide of exons 2 or 3, with few exceptions.

Generally, a SNV is considered as a polymorphic site if the minor allele presents a frequency of at least 1%. In this matter, some *HLA-G* variable sites may not be considered as true polymorphisms because they are rarely observed. Considering the 50 *HLA-G* alleles that have been officially recognized by IMGT/HLA, and taking into account the several studies evaluating the *HLA-G* coding region polymorphisms in normal or pathological conditions, only 13 alleles encoding four different HLA-G full-length molecules and a truncated one are frequently observed in worldwide populations ([@B3], [@B19], [@B23], [@B34], [@B36], [@B37], [@B68], [@B69], [@B76], [@B85]--[@B104]).

Among the high-frequency *HLA-G* coding alleles, we may find the G\*01:01:01:01, G\*01:01:01:04, G\*01:01:01:05 (present at hg19), G\*01:01:02:01, G\*01:01:03:01, G\*01:01:05, and G\*01:01:07 alleles; all carrying intronic or synonymous mutations and encoding for the same full-length HLA-G molecule known as G\*01:01. *HLA-G*\*01:01:01:01 is the reference allele used by IMGT/HLA, it was the first one described ([@B2]) and usually the most common allele in all populations studied so far. Among the frequent ones, we also find the G\*01:03:01:01 allele that is characterized by a non-synonymous mutation at position 292, codon 31, exchanging a Threonine by a Serine, encoding the full-length molecule known as G\*01:03. Another group of alleles are represented by G\*01:04:01, G\*01:04:03, and G\*01:04:04, all of them encoding the same molecule known as G\*01:04. They are characterized by a non-synonymous mutation at position 755, codon 110, exchanging a Leucine by an Isoleucine, and by other synonymous mutations. The null allele, G\*01:05N, which is associated with a truncated HLA-G molecule due to a deletion of a cytosine around codon 130 that changes the reading frame, is also very frequent in some African, Asian, and admixed populations. Finally, the last frequent allele is G\*01:06, which is characterized by a non-synonymous mutation at position 1799, codon 258, exchanging a Threonine by a Methionine, encoding a molecule known as G\*01:06. Other *HLA-G* alleles are sporadically found around the world, but only the ones presented above have been described at polymorphic frequencies.

However, the variability in the *HLA-G* coding region may be higher than the one presented by IMGT/HLA, because IMGT/HLA only presents alleles that were cloned, sequenced, and properly characterized by the researchers. In addition, most of the known alleles are not fully characterized, presenting only some exons sequenced. Therefore, the variability at the *HLA-G* coding region may be greater than the one reported so far.

The reevaluation of the *HLA-G* sequencing data from the 1000Genomes Project indicated that the *HLA-G* coding region is indeed much conserved and just a few new coding alleles are frequently found worldwide. The approach described earlier evidenced the presence of 81 SNVs in the *HLA-G* coding region, as described in Table [2](#T2){ref-type="table"}. Some of these variation sites are truly polymorphic, while some might be considered as mutations. In addition, some of these new sites are not represented in the IMGT/HLA database and might represent new *HLA-G* alleles.

###### 

**List of all variation sites found in the *HLA-G* coding. region, their genomic positions on chromosome 6 relative to hg19 and the *HLA-G* gene, and their allele frequencies considering all populations of the 1000Genomes Project (Phase 1)**.

  Genomic position (hg19)   SNPid         *HLA-G*   IMGT   Allele 1   Allele 1   Allele 2   Allele 2   Annotation
  ------------------------- ------------- --------- ------ ---------- ---------- ---------- ---------- ----------------------
  29795636                  rs1630223     15        \*     G          0.4967     A          0.5033     Synonymous
  29795657                  rs1630185     36        \*     G          0.4967     A          0.5033     Synonymous
  29795667                  .             46               G          0.9991     T          0.0009     Non-synonymous
  29795720                  rs56388903    99        \*     A          0.1120     G          0.8880     Intronic
  29795747                  rs6932888     126       \*     G          0.7156     C          0.2844     Intronic
  29795751                  rs6932596     130       \*     C          0.7161     T          0.2839     Intronic
  29795768                  rs1629329     147       \*     T          0.4396     C          0.5604     Intronic
  29795809                  rs1628628     188       \*     C          0.5669     T          0.4331     Intronic
  29795822                  .             201              A          0.9963     G          0.0037     Splice site acceptor
  29795840                  .             219              G          0.9967     T          0.0033     Non-synonymous
  29795913                  rs41551813    292       \*     A          0.9503     T          0.0497     Non-synonymous
  29795914                  rs72558173    293       \*     C          0.9986     T          0.0014     Non-synonymous
  29795918                  rs80153902    297       \*     G          0.9958     A          0.0042     Synonymous
  29795927                  rs72558174    306       \*     G          0.9972     A          0.0028     Synonymous
  29795945                  rs9258495     324       \*     G          0.9991     T          0.0009     Synonymous
  29795987                  rs78627024    366       \*     G          0.9972     A          0.0028     Synonymous
  29795993                  rs1130355     372       \*     G          0.4967     A          0.5033     Synonymous
  29796103                  rs1626038     482       \*     T          0.4340     C          0.5660     Intronic
  29796106                  rs17875399    485       \*     G          0.9526     T          0.0474     Intronic
  29796114                  .             493              G          0.9991     A          0.0009     Intronic
  29796115                  rs1736927     494       \*     A          0.4336     C          0.5665     Intronic
  29796119                  rs201510147   498              G          0.9986     A          0.0014     Intronic
  29796126                  rs3215482     505       \*     A          0.4828     AC         0.5172     Intronic
  29796128                  .             507       \*     C          0.9517     A          0.0483     Intronic
  29796149                  .             528              A          0.9967     C          0.0033     Intronic
  29796152                  rs1625907     531       \*     G          0.4819     C          0.5181     Intronic
  29796228                  .             607              G          0.9981     A          0.0019     Intronic
  29796234                  rs375939243   613       \*     CA         0.4991     C          0.5009     Intronic
  29796245                  .             624       \*     T          0.9991     C          0.0009     Intronic
  29796257                  rs1625035     636       \*     C          0.4493     T          0.5507     Intronic
  29796265                  rs17875401    644       \*     G          0.9493     T          0.0507     Intronic
  29796273                  .             652              C          0.9981     T          0.0019     Intronic
  29796306                  rs1624337     685       \*     G          0.4986     A          0.5014     Intronic
  29796327                  rs1130356     706       \*     C          0.7621     T          0.2379     Synonymous
  29796348                  rs79303923    727       \*     C          0.9981     T          0.0019     Synonymous
  29796362                  .             741       \*     C          0.9991     G          0.0009     Non-synonymous
  29796369                  rs3873252     748       \*     A          0.9345     T          0.0655     Synonymous
  29796376                  rs12722477    755       \*     C          0.8053     A          0.1947     Non-synonymous
  29796434                  rs41557518    813       \*     AC         0.9642     A          0.0358     Frame Shift
  29796492                  rs17875402    871       \*     G          0.9944     A          0.0056     Synonymous
  29796637                  rs17875403    1016      \*     C          0.9949     T          0.0051     Intronic
  29796640                  rs1632942     1019      \*     T          0.4475     C          0.5525     Intronic
  29796675                  rs17875404    1054      \*     G          0.9503     T          0.0497     Intronic
  29796685                  rs1632941     1064      \*     T          0.4972     C          0.5028     Intronic
  29796700                  rs148061958   1079             C          0.9972     T          0.0028     Intronic
  29796725                  rs370704534   1104             C          0.9981     G          0.0019     Intronic
  29796749                  rs62391965    1128      \*     C          0.9345     A          0.0655     Intronic
  29796752                  .             1131             A          0.9991     T          0.0009     Intronic
  29796768                  rs1632940     1147      \*     T          0.2040     C          0.7960     Intronic
  29796800                  rs140935623   1179             A          0.9981     G          0.0019     Intronic
  29796838                  rs1736923     1217      \*     A          0.4963     G          0.5037     Intronic
  29796934                  rs114041958   1313      \*     G          0.9507     A          0.0493     Intronic
  29796935                  rs1632939     1314      \*     G          0.4972     A          0.5028     Intronic
  29796986                  rs1632938     1365      \*     G          0.4972     A          0.5028     Intronic
  29797043                  rs145023077   1422             C          0.9912     T          0.0088     Intronic
  29797052                  rs116139267   1431             C          0.9967     T          0.0033     Intronic
  29797073                  rs188836562   1452             G          0.9991     C          0.0009     Intronic
  29797155                  rs17875405    1534      \*     G          0.9503     C          0.0497     Intronic
  29797173                  rs1736920     1552      \*     A          0.4470     G          0.5530     Intronic
  29797195                  .             1574             A          0.9986     AC         0.0014     Frame Shift
  29797211                  rs41562616    1590      \*     C          0.9503     T          0.0497     Synonymous
  29797380                  rs200931762   1759             G          0.9991     A          0.0009     Non-synonymous
  29797420                  rs12722482    1799      \*     C          0.9698     T          0.0302     Non-synonymous
  29797421                  rs76951509    1800      \*     G          0.9963     A          0.0037     Synonymous
  29797448                  rs17875406    1827      \*     G          0.9554     A          0.0446     Synonymous
  29797553                  rs1632937     1932      \*     G          0.4972     C          0.5028     Intronic
  29797639                  rs1049033     2018      \*     C          0.7742     T          0.2258     Synonymous
  29797696                  rs1130363     2075      \*     A          0.4470     G          0.5530     Synonymous
  29797782                  rs1611627     2161      \*     T          0.5627     C          0.4373     Intronic
  29797899                  rs1632934     2278      \*     T          0.4972     C          0.5028     Intronic
  29797933                  rs1632933     2312      \*     C          0.4972     T          0.5028     Intronic
  29797951                  rs1736912     2330      \*     A          0.4972     G          0.5028     Intronic
  29798029                  .             2408             T          0.9991     A          0.0009     Intronic
  29798033                  rs17179080    2412             G          0.9707     A          0.0293     Intronic
  29798039                  rs1632932     2418      \*     G          0.4972     A          0.5028     Intronic
  29798083                  rs114038308   2462      \*     C          0.9345     T          0.0655     Intronic
  29798140                  rs915667      2519      \*     A          0.5084     G          0.4916     Intronic
  29798248                  rs186170315   2627             G          0.9991     A          0.0009     Intronic
  29798419                  rs915670      2798      \*     G          0.7742     A          0.2258     Intronic
  29798425                  rs915669      2804      \*     G          0.4480     T          0.5520     Intronic
  29798459                  rs915668      2838      \*     C          0.4480     G          0.5520     Intronic

*\*Denotes a variation site that is recognized by the IMGT/HLA database*.

As observed in Table [2](#T2){ref-type="table"}, most of the 81 variation sites occur in introns (54 sites) or in exons as synonymous changes (16 sites). Thus, 86.4% of all variants are associated with the same HLA-G full-length molecule, unless they somehow influence *HLA-G* splicing pattern. Among the ones that might be related to different HLA-G full-length proteins, we may find two frameshift mutations: the first associated with the G\*01:05N null allele and the second representing a low-frequency variation site not recognized by IMGT/HLA (genomic position 29797195); one variation site associated with a splicing acceptor site (genomic position 29795822, HLA-G position + 201) and eight non-synonymous modifications, most of them recognized by IMGT/HLA. Interestingly, one synonymous modification was found presenting a high frequency (2.93%) and is not associated with any known *HLA-G* allele described so far (*HLA-G* position + 2412, rs17179080, Table [2](#T2){ref-type="table"}). Although a triallelic SNV is described at exon 2 (HLA-G position + 372), associated with the G\*01:04:02 allele, we did not find the third allele in the present data.

As described earlier, haplotypes were inferred considering all variation sites found in the *HLA-G* region. When the coding region is isolated from these haplotypes, we found 93 different *HLA-G* coding haplotypes, a number far higher than the number of *HLA-G* alleles officially recognized. The complete table of haplotypes is available upon request. Table [3](#T3){ref-type="table"} describes all coding haplotypes presenting a minimum global frequency of 1% and the closest known *HLA-G* allele in terms of sequence similarity. It should be mentioned that non-variable positions for the haplotypes presented in Table [3](#T3){ref-type="table"} were removed. Although 93 different haplotypes were inferred, only 11 present a frequency higher than 1%. Of those, 10 were compatible with a specific allele described at the IMGT/HLA database and mentioned earlier as high-frequency alleles that usually occur in any population, and 1 is a new allele that is close to G\*01:01:01:01 but presents the frequent nucleotide change at position + 2412, not recognized by IMGT/HLA. As previously observed in other studies, the most frequent *HLA-G* allele is G\*01:01:01:01, followed by G\*01:01:02:01 and G\*01:04:01. These 11 haplotypes or coding alleles do represent 88.8% of all *HLA-G* coding haplotypes and are associated with only four different HLA-G full-length molecules and a truncated one. Moreover, taking into account these 11 haplotypes, at least 60.87% of all HLA-G full-length molecules would be the same (from G\*01:01:01:01, G\*01:01:02:01, G:01:01:03:03, G\*01:01:01:04, and G\*01:01:01:01new) and a higher proportion is expected if other rare haplotypes are considered.

###### 

**List of *HLA-G* coding haplotypes presenting a global frequency higher than 1%, considering all populations of the 1000Genomes Project (Phase 1)**.

  HLA-G position                             Genomic position on chromosome 6 (hg19)   SNPid         G\*01:01:01:01   G\*01:01:01:01new   G\*01:01:01:04   G\*01:01:01:05   G\*01:01:02:01   G\*01:01:03:03   G\*01:03:01:02   G\*01:04:01   G\*01:04:04   G\*01:05N   G\*01:06
  ------------------------------------------ ----------------------------------------- ------------- ---------------- ------------------- ---------------- ---------------- ---------------- ---------------- ---------------- ------------- ------------- ----------- ----------
  15                                         29795636                                  rs1630223     G                G                   G                G                A                A                G                A             A             A           A
  36                                         29795657                                  rs1630185     G                G                   G                G                A                A                G                A             A             A           A
  99                                         29795720                                  rs56388903    G                G                   G                A                G                G                G                G             G             G           G
  126                                        29795747                                  rs6932888     C                C                   G                G                G                G                G                G             G             G           G
  130                                        29795751                                  rs6932596     T                T                   C                C                C                C                C                C             C             C           C
  147                                        29795768                                  rs1629329     T                T                   T                T                C                C                C                C             C             C           C
  188                                        29795809                                  rs1628628     C                C                   C                C                T                C                C                T             T             T           T
  292                                        29795913                                  rs41551813    A                A                   A                A                A                A                T                A             A             A           A
  372                                        29795993                                  rs1130355     G                G                   G                G                A                A                G                A             A             A           A
  482                                        29796103                                  rs1626038     T                T                   T                T                C                C                C                C             C             C           C
  485                                        29796106                                  rs17875399    G                G                   G                G                G                G                T                G             G             G           G
  494                                        29796115                                  rs1736927     A                A                   A                A                C                C                C                C             C             C           C
  505                                        29796126                                  rs3215482     --               --                  --               --               C                C                --               C             C             C           C
  507                                        29796128                                                C                C                   C                C                C                C                A                C             C             C           C
  531                                        29796152                                  rs1625907     G                G                   G                G                C                C                G                C             C             C           C
  613                                        29796234                                  rs375939243   A                A                   A                A                --               --               A                --            --            --          --
  636                                        29796257                                  rs1625035     C                C                   C                C                T                T                T                T             T             T           T
  644                                        29796265                                  rs17875401    G                G                   G                G                G                G                T                G             G             G           G
  685                                        29796306                                  rs1624337     G                G                   G                G                A                A                G                A             A             A           A
  706                                        29796327                                  rs1130356     C                C                   C                C                T                C                C                C             C             T           T
  748                                        29796369                                  rs3873252     A                A                   A                A                A                T                A                A             A             A           A
  755                                        29796376                                  rs12722477    C                C                   C                C                C                C                C                A             A             C           C
  813                                        29796434                                  rs41557518    C                C                   C                C                C                C                C                C             C             --          C
  1019                                       29796640                                  rs1632942     T                T                   T                T                C                C                C                C             C             C           C
  1054                                       29796675                                  rs17875404    G                G                   G                G                G                G                T                G             G             G           G
  1064                                       29796685                                  rs1632941     T                T                   T                T                C                C                T                C             C             C           C
  1128                                       29796749                                  rs62391965    C                C                   C                C                C                A                C                C             C             C           C
  1147                                       29796768                                  rs1632940     C                C                   T                T                C                C                T                C             C             C           C
  1217                                       29796838                                  rs1736923     A                A                   A                A                G                G                A                G             G             G           G
  1313                                       29796934                                  rs114041958   G                G                   G                G                G                G                A                G             G             G           G
  1314                                       29796935                                  rs1632939     G                G                   G                G                A                A                G                A             A             A           A
  1365                                       29796986                                  rs1632938     G                G                   G                G                A                A                G                A             A             A           A
  1534                                       29797155                                  rs17875405    G                G                   G                G                G                G                C                G             G             G           G
  1552                                       29797173                                  rs1736920     A                A                   A                A                G                G                G                G             G             G           G
  1590                                       29797211                                  rs41562616    C                C                   C                C                C                C                T                C             C             C           C
  1799                                       29797420                                  rs12722482    C                C                   C                C                C                C                C                C             C             C           T
  1827                                       29797448                                  rs17875406    G                G                   G                G                G                G                G                G             A             G           G
  1932                                       29797553                                  rs1632937     G                G                   G                G                C                C                G                C             C             C           C
  2018                                       29797639                                  rs1049033     C                C                   C                C                T                C                C                C             C             T           T
  2075                                       29797696                                  rs1130363     A                A                   A                A                G                G                G                G             G             G           G
  2161                                       29797782                                  rs1611627     T                T                   T                T                C                T                T                C             C             C           C
  2278                                       29797899                                  rs1632934     T                T                   T                T                C                C                T                C             C             C           C
  2312                                       29797933                                  rs1632933     C                C                   C                C                T                T                C                T             T             T           T
  2330                                       29797951                                  rs1736912     A                A                   A                A                G                G                A                G             G             G           G
  2412                                       29798033                                  rs17179080    G                A                   G                G                G                G                G                G             G             G           G
  2418                                       29798039                                  rs1632932     G                G                   G                G                A                A                G                A             A             A           A
  2462                                       29798083                                  rs114038308   C                C                   C                C                C                T                C                C             C             C           C
  2519                                       29798140                                  rs915667      A                A                   A                A                G                G                A                G             G             G           G
  2798                                       29798419                                  rs915670      G                G                   G                G                A                G                G                G             G             A           A
  2804                                       29798425                                  rs915669      G                G                   G                G                T                T                T                T             T             T           T
  2838                                       29798459                                  rs915668      C                C                   C                C                G                G                G                G             G             G           G
                                                                                                                                                                                                                                                                       
  Global haplotype frequency (2*n* = 2152)   0.2528                                    0.0200        0.0376           0.0911              0.1445           0.0627           0.0446           0.1329           0.0404           0.0330        0.0283                    

*HLA-G* coding haplotypes were converted into coding alleles based on the International Immunogenetics Database (IMGT/HLA). The new *HLA-G* allele presenting a frequency of about 1% is defined with the suffix "new."

The haplotypes listed in Table [3](#T3){ref-type="table"} do present heterogeneous frequencies among the 1000Genomes populations (Table [4](#T4){ref-type="table"}). The G\*01:01:01:01 allele, for example, is very frequent among Europeans and Asians, presents intermediate frequencies among admixed populations and lower frequencies in African populations, while an opposite pattern is observed for the G\*01:05N null allele. In addition, allele G\*01:01:03:03 is absent or very rare in African populations, and the G\*01:04:04, G\*01:01:01:04, and G\*01:01:01:01new alleles are absent in Asians.

###### 

**The most frequent *HLA-G* coding haplotypes and their frequencies among the 1000Genomes Project (Phase 1) populations**.

  *HLA-G* coding alleles according to IMGT/HLA[^a^](#tfn1){ref-type="table-fn"}   Europe   Asia     Africa   Admixed                                                                                    
  ------------------------------------------------------------------------------- -------- -------- -------- --------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  G\*01:01:01:01                                                                  0.3824   0.2755   0.2989   0.3370    0.2857   0.2813   0.3900   0.2360   0.0690   0.1489   0.1271   0.2339   0.2182   0.1810
  G\*01:01:02:01                                                                  0.1824   0.1735   0.1954   0.1196    0.2500   0.0938   0.0350   0.1742   0.1379   0.1436   0.1780   0.2097   0.1000   0.1552
  G\*01:04:01                                                                     0.0647   0.1020   0.0517   0.0543    0.0714   0.2656   0.2400   0.3764   0.0402   0.0106   0.0339   0.1532   0.1364   0.1810
  G\*01:01:01:05                                                                  0.1529   0.1429   0.1092   0.2609    0.1071   0.0469   0.0150   0.0056   0.0632   0.0319   0.0339   0.0806   0.1182   0.1293
  G\*01:01:03:03                                                                  0.0529   0.0408   0.0920   0.0435    0.0357   0.1719   0.2050   0.0337   0.0000   0.0000   0.0085   0.0484   0.0455   0.0086
  G\*01:03:01:02                                                                  0.0353   0.0306   0.0230   0.0163    0.0000   0.0260   0.0000   0.0169   0.0690   0.0798   0.1186   0.0968   0.0818   0.0603
  G\*01:04:04                                                                     0.0235   0.0306   0.0115   0.0054    0.0000   0.0000   0.0000   0.0000   0.2299   0.0745   0.1102   0.0081   0.0273   0.0259
  G\*01:01:01:04                                                                  0.0118   0.0153   0.0632   0.0109    0.0714   0.0000   0.0000   0.0000   0.0747   0.1011   0.0763   0.0403   0.0727   0.0603
  G\*01:05N                                                                       0.0059   0.0408   0.0000   0.0109    0.0000   0.0417   0.0150   0.0056   0.1207   0.0638   0.0847   0.0242   0.0000   0.0172
  G\*01:06                                                                        0.0412   0.0714   0.0632   0.0272    0.1071   0.0260   0.0100   0.0056   0.0000   0.0053   0.0085   0.0242   0.0273   0.0431
  G\*01:01:01:01new                                                               0.0059   0.0153   0.0115   0.0000    0.0000   0.0000   0.0000   0.0000   0.0460   0.0585   0.0593   0.0242   0.0364   0.0345

^a^*HLA-G* coding haplotypes were converted into coding alleles based on the International Immunogenetics Database (IMGT/HLA). The new *HLA-G* allele presenting high frequencies is defined with the suffix "new."

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

*Haplotypes are ordered according to their global frequency*.

*HLA-G* 3′ Untranslated Region Variability and Haplotypes {#S5}
=========================================================

The reevaluation of the *HLA-G* sequencing data indicated that its 3′UTR presents several high-frequency variation sites in a short segment. The approach described earlier evidenced as much as 17 variation sites in this short region, as described in Table [5](#T5){ref-type="table"}. Some of these variation sites are polymorphic and have been previously described in several studies that evaluated the *HLA-G* 3′UTR ([@B38], [@B69], [@B76], [@B88], [@B105]--[@B117]), while some might be considered as mutations. In general, nine variation sites can be considered as true polymorphisms. It should be noted that the nomenclature used to designate *HLA-G* 3′UTR variation sites is based on our previous reports, being designated as UTR-1, UTR-2, and so forth ([@B88]). In this matter, the 14-bp insertion (rs371194629), although less frequent and not represented in the hg19 human genome, is considered to be the ancestral allele and should be counted for designate *HLA-G* 3′UTR positions.

###### 

**List of all variation sites found in the *HLA-G* 3′ untranslated region, their positions regarding hg19 and the *HLA-G* gene, and their allele frequencies considering all populations of the 1000Genomes Project (Phase 1)**.

  Genomic    SNPid         HLA-G   Allele 1   Allele 1   Allele 2          Allele 2
  ---------- ------------- ------- ---------- ---------- ----------------- ----------
  29798563                 2942    T          0.9986     C                 0.0014
  29798581   rs371194629   2960    G          0.7068     GATTTGTTCATGCCT   0.2932
  29798608                 3001    C          0.9986     T                 0.0014
  29798610   rs1707        3003    C          0.1152     T                 0.8848
  29798617   rs1710        3010    G          0.4610     C                 0.5390
  29798634   rs17179101    3027    C          0.9359     A                 0.0641
  29798639   rs146339774   3032    G          0.9967     C                 0.0033
  29798642   rs17179108    3035    C          0.8829     T                 0.1171
  29798659                 3052    C          0.9991     T                 0.0009
  29798699   rs180827037   3092    G          0.9986     T                 0.0014
  29798728   rs138249160   3121    T          0.9967     C                 0.0033
  29798749   rs1063320     3142    C          0.4484     G                 0.5516
  29798784                 3177    G          0.9991     T                 0.0009
  29798790   rs187320344   3183    G          0.9991     A                 0.0009
  29798794   rs9380142     3187    A          0.7045     G                 0.2955
  29798803   rs1610696     3196    C          0.7625     G                 0.2375
  29798834   rs1233331     3227    G          0.9707     A                 0.0293

When the 3′UTR segment is isolated from the 200 extended haplotypes found, we observe 41 different haplotypes for this region. Table [6](#T6){ref-type="table"} presents all haplotypes that reached a global frequency higher than 1% and the complete table of haplotypes is available upon request. Monomorphic positions considering these high-frequency haplotypes are removed from Table [6](#T6){ref-type="table"}. Considering the global frequency of each haplotype, it is noteworthy that only nine haplotypes account for more than 95% of all haplotypes found. These haplotypes were named according to the previous studies addressing the *HLA-G* 3′UTR variability ([@B38], [@B69], [@B76], [@B88], [@B105]--[@B117]).

###### 

**The most frequent *HLA-G* 3′ untranslated region haplotypes presenting frequencies higher than 1% considering all populations of the 1000Genomes Project (Phase 1)**.

  dbSNP          rs371194629   rs1707   rs1710   rs17179101   rs17179108   rs1063320   rs9380142   rs1610696   rs1233331   Global
  -------------- ------------- -------- -------- ------------ ------------ ----------- ----------- ----------- ----------- --------
  UTR-1          Del           T        G        C            C            C           G           C           G           0.2904
  UTR-2          Ins           T        C        C            C            G           A           G           G           0.1938
  UTR-3          Del           T        C        C            C            G           A           C           G           0.1938
  UTR-4          Del           C        G        C            C            C           A           C           G           0.1083
  UTR-7          Ins           T        C        A            T            G           A           C           G           0.0558
  UTR-10         Del           T        C        C            C            G           A           G           G           0.0367
  UTR-5          Ins           T        C        C            T            G           A           C           G           0.0358
  UTR-18         Del           T        G        C            C            C           A           C           A           0.0283
  UTR-6          Del           T        G        C            C            C           A           C           G           0.0125
  Major allele   Del           T        C        C            C            G           A           C           G           
  Frequency      0.7068        0.8848   0.5390   0.9359       0.8829       0.5516      0.7045      0.7625      0.9707      

**HLA-G* 3′ untranslated region haplotypes were named following the same nomenclature used in the previous studies ([@B69], [@B76], [@B88], [@B110])*.

*Haplotypes are ordered according to their global frequency*.

The haplotypes found considering the reevaluation of the 1000Genomes data are consistent with the ones found in several other populations, and some haplotypes that were previously considered as rare ones (such as UTR-10 and UTR-18) are actually more frequent than previously thought considering all populations pooled together (global frequency). Some rare SNVs that were previously described using Sanger sequencing, such as the one at position +3001 ([@B69], [@B110], [@B111]), and others that were described in studies evaluating the 1000Genomes data, such as +3032, +3052, +3092, +3121, and +3227, were also detected in this reevaluation (Table [5](#T5){ref-type="table"}). In addition, it should be pointed out that the 14-bp polymorphism, which is absent at the 1000Genomes initial released VCF files, was retrieved from the raw sequence data and its genotypes were inferred for most of the samples.

Similar to the *HLA-G* coding region, a heterogeneous distribution of these nine 3′UTR haplotypes is observed among the 1000Genomes populations (Table [7](#T7){ref-type="table"}). The UTR-1 haplotype, for example, is very common in European populations, but presents lower frequencies in populations from Africa. The UTR-7 haplotype is absent or rare in populations of African ancestry, and haplotypes UTR-6 and UTR-18 are absent or rare in Asia. The 3′UTR haplotype frequencies in admixed populations are close to the ones reported for other admixed populations such as Brazilians ([@B76], [@B88], [@B110], [@B111]). In addition, the frequencies observed for the 1000Genomes African populations are close to the ones reported for other African populations described in isolated reports ([@B108], [@B116], [@B117]). Moreover, the frequencies reported here are close to the ones presented for the same data in another manuscript ([@B69]), with some minor differences since this latter manuscript only imputed the 14-bp polymorphism and used the original 1000Genomes VCF data.

###### 

**The most frequent *HLA-G* 3′ untranslated region haplotypes and their frequencies among the 1000Genomes Project (Phase 1) populations**.

  *HLA-G* 3′UTR haplotypes[^a^](#tfn2){ref-type="table-fn"}   Europe   Asia     Africa   Admixed                                                                                    
  ----------------------------------------------------------- -------- -------- -------- --------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  UTR-1                                                       0.3882   0.2959   0.3333   0.3533    0.3214   0.2865   0.4200   0.2472   0.1322   0.2287   0.2288   0.2823   0.2909   0.2241
  UTR-3                                                       0.0882   0.1276   0.0575   0.0652    0.0714   0.2813   0.2600   0.4944   0.2989   0.1170   0.1610   0.1532   0.1818   0.2328
  UTR-2                                                       0.2471   0.2398   0.2644   0.1739    0.3929   0.1510   0.0500   0.1685   0.1667   0.2340   0.2627   0.2419   0.1000   0.2155
  UTR-4                                                       0.1529   0.1378   0.1092   0.2826    0.1071   0.0469   0.0200   0.0056   0.1322   0.1117   0.0508   0.0887   0.1273   0.1466
  UTR-7                                                       0.0471   0.0408   0.0747   0.0435    0.0357   0.1563   0.1800   0.0281   0.0000   0.0000   0.0085   0.0403   0.0455   0.0000
  UTR-10                                                      0.0000   0.0714   0.0230   0.0380    0.0000   0.0313   0.0100   0.0225   0.0977   0.0585   0.0339   0.0161   0.0364   0.0345
  UTR-5                                                       0.0353   0.0255   0.0172   0.0163    0.0000   0.0156   0.0000   0.0169   0.0460   0.0479   0.1017   0.0806   0.0909   0.0431
  UTR-18                                                      0.0118   0.0153   0.0517   0.0109    0.0714   0.0000   0.0000   0.0000   0.0172   0.0798   0.0508   0.0323   0.0727   0.0603
  UTR-6                                                       0.0059   0.0153   0.0000   0.0000    0.0000   0.0000   0.0000   0.0000   0.0747   0.0266   0.0254   0.0081   0.0091   0.0000
  others                                                      0.0235   0.0306   0.0690   0.0163    0.0000   0.0313   0.0600   0.0169   0.0345   0.0957   0.0763   0.0565   0.0455   0.0431

*^a^*HLA-G* 3′ untranslated haplotypes were named following the same nomenclature used in the previous studies ([@B69], [@B76], [@B88], [@B110])*.

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

*Haplotypes are ordered according to their global frequency*.

*HLA-G* 5′ Promoter Region Variability and Haplotypes {#S6}
=====================================================

As previously discussed, there is no consensus regarding where the *HLA-G* transcription starts. Considering NCBI and NM_002127.5, the *HLA-G* transcription starts 866 nucleotides upstream the initiation codon ATG. However, most of the studies performed so far regarding the *HLA-G* promoter structure did consider 1500 nucleotides upstream the main initiation codon ATG as the *HLA-G* promoter region. In this scenario, only SNVs above −866 should be considered as promoter SNVs (or SNVs from the upstream regulatory region) and the ones between −866 and −1 should be considered as 5′UTR SNVs. Nevertheless, despite of this inconsistency and considering the fact that there is no consensus yet regarding the *HLA-G* initial transcription starting point, in the present work we considered all SNVs upstream the main translation start point as promoter (5′ upstream regulatory region) SNVs.

The approach described earlier evidenced the presence of 35 SNVs in the *HLA-G* promoter region, as described in Table [8](#T8){ref-type="table"}. Among them, 26 of all variable sites (74.3%) can be considered as true polymorphisms (minor allele frequency above 1%), and at least 11 present frequencies around 50%. In addition, the trialleic SNP at position −725, as well as other known indels at the promoter region, was properly recovered.

###### 

**List of all variation sites found at the *HLA-G* 5′ promoter region, their positions regarding hg19 and the *HLA-G* gene, and their allele frequencies considering all populations of the 1000Genomes Project (Phase 1)**.

  Genomic    SNPid         HLA-G       Allele 1   Allele 1   Allele 2   Allele 2   Allele 3   Allele 3
  ---------- ------------- ----------- ---------- ---------- ---------- ---------- ---------- ----------
  29794317   rs1736936     −1305       G          0.4995     A          0.5005                
  29794443   rs1736935     −1179       A          0.4466     G          0.5534                
  29794467   rs3823321     −1155       G          0.8020     A          0.1980                
  29794482   rs1736934     −1140       A          0.6952     T          0.3048                
  29794484   rs17875389    −1138       A          0.9493     G          0.0507                
  29794501   rs3115630     −1121       T          0.0428     C          0.9572                
  29794524   rs146374870   −1098       G          0.9972     A          0.0028                
  29794658   rs1632947     −964        G          0.4986     A          0.5014                
  29794700   rs370338057   −922        C          0.9981     A          0.0019                
  29794812   rs182801644   −810        C          0.9986     T          0.0014                
  29794860   rs1632946     −762        C          0.4972     T          0.5028                
  29794897   rs1233334     −725        G          0.0953     C          0.8550     T          0.0497
  29794906   rs2249863     −716        T          0.4963     G          0.5037                
  29794933   rs2735022     −689        A          0.4963     G          0.5037                
  29794956   rs35674592    −666        G          0.4981     T          0.5019                
  29794976   rs17875391    −646        A          0.9749     G          0.0251                
  29794989   rs1632944     −633        G          0.4995     A          0.5005                
  29795076   rs201221694   −546/−540   A          0.9744     AG         0.0256                
  29795081   rs368205133   −541/−533   GA         0.9545     G          0.0455                
  29795083   rs112940953   −539        A          0.9967     G          0.0033                
  29795101   rs138987412   −521        C          0.9986     A          0.0014                
  29795113   rs17875393    −509        C          0.9559     G          0.0441                
  29795136   rs1736933     −486        A          0.4991     C          0.5009                
  29795139   rs149890776   −483        A          0.9717     G          0.0283                
  29795145   rs1736932     −477        C          0.4461     G          0.5539                
  29795179   rs17875394    −443        G          0.9638     A          0.0362                
  29795222   rs17875395    −400        G          0.9559     A          0.0441                
  29795231   rs17875396    −391        G          0.9559     A          0.0441                
  29795253   rs1632943     −369        C          0.4480     A          0.5520                
  29795267   rs191630481   −355        G          0.9967     A          0.0033                
  29795338   .             −284        G          0.9991     A          0.0009                
  29795366   .             −256        TC         0.9958     T          0.0042                
  29795421   rs1233333     −201        G          0.4967     A          0.5033                
  29795472   .             −150        C          0.9977     T          0.0023                
  29795566   rs17875397    −56         C          0.9503     T          0.0497                

When the promoter region is isolated from the 200 extended haplotypes found, we observe 64 haplotypes for this region. Table [9](#T9){ref-type="table"} presents all haplotypes that reached a frequency higher than 1% and the complete table of haplotypes is available upon request. Monomorphic positions considering these frequent haplotypes were removed from Table [9](#T9){ref-type="table"}. Considering the global frequency of each haplotype, it is worth mentioning that only nine haplotypes account for more than 95% of all haplotypes found. These haplotypes were named according to previously published works addressing the *HLA-G* promoter region variability ([@B76], [@B118]--[@B120]). As previously observed for both the coding and 3′UTR regions, promoter haplotype frequencies greatly vary among populations (Table [10](#T10){ref-type="table"}).

###### 

**The most frequent *HLA-G* 5′ promoter region haplotypes presenting frequencies higher than 1% considering all populations of the 1000Genomes Project (Phase 1)**.

  SNV Identification               HLA-G Promoter Haplotypes                                                                                        
  -------------------------------- --------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --- ----
  29794317                         rs1736936                   −1305    A        G        A        G        G        G        A        G        G   G
  29794443                         rs1736935                   −1179    G        A        G        A        A        A        G        A        G   G
  29794467                         rs3823321                   −1155    G        G        A        G        G        G        A        G        G   G
  29794482                         rs1736934                   −1140    T        A        A        A        A        A        A        A        A   A
  29794484                         rs17875389                  −1138    A        A        A        A        A        A        A        A        G   G
  29794501                         rs3115630                   −1121    C        C        C        C        C        T        C        C        C   C
  29794658                         rs1632947                   −964     A        G        A        G        G        G        A        G        G   G
  29794860                         rs1632946                   −762     T        C        T        C        C        C        T        C        C   C
  29794897                         rs1233334                   −725     C        C        C        G        C        G        C        C        T   T
  29794906                         rs2249863                   −716     G        T        G        T        T        T        G        T        T   T
  29794933                         rs2735022                   −689     G        A        G        A        A        A        G        A        A   A
  29794956                         rs35674592                  −666     T        G        T        G        G        G        T        G        G   G
  29794976                         rs17875391                  −646     A        A        A        A        A        A        A        A        A   G
  29794989                         rs1632944                   −633     A        G        A        G        G        G        A        G        G   G
  29795076                         rs201221694                 −546     --       --       --       --       --       --       --       --       G   --
  29795081                         rs368205133                 −541     A        A        A        A        --       A        A        A        A   A
  29795113                         rs17875393                  −509     C        C        C        C        C        C        C        C        G   G
  29795136                         rs1736933                   −486     C        A        C        A        A        A        C        A        A   A
  29795139                         rs149890776                 −483     A        A        A        A        A        A        A        G        A   A
  29795145                         rs1736932                   −477     G        C        G        C        C        C        G        C        G   G
  29795179                         rs17875394                  −443     G        G        G        G        G        G        A        G        G   G
  29795222                         rs17875395                  −400     G        G        G        G        G        G        G        G        A   A
  29795231                         rs17875396                  −391     G        G        G        G        G        G        G        G        A   A
  29795253                         rs1632943                   −369     A        C        A        C        C        C        A        C        A   A
  29795421                         rs1233333                   −201     A        G        A        G        G        G        A        G        G   G
  29795566                         rs17875397                  −56      C        C        C        C        C        C        C        C        T   T
  29795636                         rs1630223                       15   A        G        A        G        G        G        A        G        G   G
                                                                                                                                                    
  Global Frequency (2*n* = 2152)   0.2825                      0.2728   0.1501   0.0520   0.0446   0.0418   0.0353   0.0260   0.0191   0.0149       

**HLA-G* promoter haplotypes were named following the same nomenclature used in the previous studies ([@B76], [@B118])*.

*Haplotypes are ordered according to their global frequency*.

###### 

**The most frequent *HLA-G* 5′ promoter region haplotypes and their frequencies among the 1000Genomes Project (Phase 1) populations**.

  Promoter haplotypes[^a^](#tfn3){ref-type="table-fn"}   Europe   Asia     Africa   Admixed                                                                                    
  ------------------------------------------------------ -------- -------- -------- --------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  010102a                                                0.2824   0.3418   0.3908   0.2283    0.4286   0.3385   0.2750   0.2360   0.2586   0.2713   0.2881   0.2742   0.1636   0.2328
  010101a                                                0.3941   0.2704   0.3103   0.3370    0.3214   0.2813   0.4150   0.2303   0.1379   0.2394   0.1695   0.2419   0.2182   0.1810
  010104a                                                0.0882   0.1327   0.0575   0.0652    0.0714   0.1979   0.1800   0.3820   0.2701   0.0904   0.1356   0.0806   0.1455   0.0862
  010101b                                                0.0471   0.0510   0.0230   0.1902    0.0000   0.0417   0.0100   0.0056   0.0805   0.0266   0.0339   0.0645   0.0455   0.0690
  010101f                                                0.0118   0.0255   0.0747   0.0109    0.0714   0.0000   0.0050   0.0056   0.0747   0.1277   0.0847   0.0484   0.0909   0.0603
  010101c                                                0.1059   0.0867   0.0862   0.0870    0.1071   0.0052   0.0050   0.0000   0.0000   0.0053   0.0085   0.0161   0.0727   0.0603
  010104b                                                0.0000   0.0000   0.0000   0.0000    0.0000   0.0781   0.0800   0.0899   0.0000   0.0000   0.0085   0.0726   0.0273   0.1379
  010101d                                                0.0059   0.0153   0.0115   0.0000    0.0000   0.0000   0.0000   0.0000   0.0632   0.0691   0.0763   0.0403   0.0636   0.0431
  0103a                                                  0.0235   0.0153   0.0115   0.0163    0.0000   0.0156   0.0000   0.0169   0.0000   0.0000   0.0339   0.0887   0.0364   0.0345
  0103e                                                  0.0059   0.0051   0.0057   0.0000    0.0000   0.0104   0.0000   0.0000   0.0402   0.0479   0.0339   0.0081   0.0273   0.0259

*^a^*HLA-G* promoter lineages were named according to the previous studies ([@B76], [@B118])*.

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

*Haplotypes are ordered according to their global frequency*.

*HLA-G* Extended Haplotypes {#S7}
===========================

As described earlier, 200 extended haplotypes were inferred considering the whole *HLA-G* sequence encompassing the promoter, coding, and 3′UTR segments. Since there is no official nomenclature for the entire MHC genes, the *HLA-G* extended haplotypes were named according to the nomenclature adopted for each *HLA-G* segment. As already observed for some populations ([@B76], [@B88], [@B118]--[@B120]), the promoter haplotypes are usually associated with the same coding and 3′UTR haplotypes (Table [11](#T11){ref-type="table"}). For example, promoter haplotype 010101a is usually associated with the coding allele G\*01:01:01:01 and the 3′UTR haplotype named UTR-1. The same phenomenon is observed for each of the main *HLA-G* promoter, coding, or 3′UTR haplotypes. In this matter, only 24 extended *HLA-G* haplotypes were found presenting a minimum frequency of 0.5% and representing more than 85% of all haplotypes, and only 15 present frequencies higher than 1%.

###### 

**The most frequent *HLA-G* extended haplotypes presenting frequencies higher than 0.5% considering all populations of the 1000Genomes Project (Phase 1)**.

  Promoter haplotype[^a^](#tfn4){ref-type="table-fn"}   Coding allele[^b^](#tfn5){ref-type="table-fn"}   3′UTR haplotype[^c^](#tfn6){ref-type="table-fn"}   *HLA-G* lineage[^d^](#tfn7){ref-type="table-fn"}   Global frequency   Extended haplotype[^e^](#tfn8){ref-type="table-fn"}
  ----------------------------------------------------- ------------------------------------------------ -------------------------------------------------- -------------------------------------------------- ------------------ -----------------------------------------------------
  010101a                                               G\*01:01:01:01                                   UTR-1                                              HG010101a                                          0.24257            G010101a/G\*01:01:01:01/UTR-1
  010102a                                               G\*01:01:02:01                                   UTR-2                                              HG010102                                           0.11803            G010102a/G\*01:01:02:01/UTR-2
  0104a                                                 G\*01:04:01                                      UTR-3                                              HG0104                                             0.09108            G0104a/G\*01:04:01/UTR-3
  010102a                                               G\*01:01:03:03                                   UTR-7                                              HG010103                                           0.05112            G010102a/G\*01:01:03:03/UTR-7
  010101b                                               G\*01:01:01:05                                   UTR-4                                              HG010101c                                          0.04786            G010101b/G\*01:01:01:05/UTR-4
  010101c                                               G\*01:01:01:05                                   UTR-4                                              HG010101c                                          0.04136            G010101c/G\*01:01:01:05/UTR-4
  0104a                                                 G\*01:04:04                                      UTR-3                                              HG0104                                             0.03810            G0104a/G\*01:04:04/UTR-3
  0104b                                                 G\*01:04:01                                      UTR-3                                              HG0104                                             0.03392            G0104b/G\*01:04:01/UTR-3
  010101f                                               G\*01:01:01:04                                   UTR-18                                             HG010101b                                          0.02835            G010101f/G\*01:01:01:04/UTR-18
  010102a                                               G\*01:06                                         UTR-2                                              HG010102                                           0.02556            G010102a/G\*01:06/UTR-2
  010101d                                               G\*01:01:01:01new                                UTR-1                                              HG010101a                                          0.01859            G010101d/G\*01:01:01:01new/UTR-1
  010102a                                               G\*01:05N                                        UTR-10                                             HG010102                                           0.01812            G010102a/G\*01:05N/UTR-10
  0103a                                                 G\*01:03:01:02                                   UTR-5                                              HG0103                                             0.01766            G0103a/G\*01:03:01:02/UTR-5
  010102a                                               G\*01:05N                                        UTR-2                                              HG010102                                           0.01255            G010102a/G\*01:05N/UTR-2
  010102a                                               G\*01:01:02:01                                   UTR-10                                             HG010102                                           0.01115            G010102a/G\*01:01:02:01/UTR-10
  0104a                                                 G\*01:04:01-Like                                 UTR-3                                              HG0104                                             0.00883            G0104a/G\*01:04:01-Like/UTR-3
  010101d                                               G\*01:01:01:04-Like                              UTR-1                                              HG010101a                                          0.00651            G010101d/G\*01:01:01:04-Like/UTR-1
  0103c                                                 G\*01:03:01:02                                   UTR-5                                              HG0103                                             0.00651            G0103c/G\*01:03:01:02/UTR-5
  010101f                                               G\*01:01:01:04                                   UTR-6                                              HG010101b                                          0.00604            G010101f/G\*01:01:01:04/UTR-6
  010101a                                               G\*01:01:01:06                                   UTR-4                                              HG010101\*                                         0.00604            G010101a/G\*01:01:01:06/UTR-4
  010102a                                               G\*01:01:03:03                                   UTR-7-Like                                         HG010103                                           0.00604            G010102a/G\*01:01:03:03/UTR-7-Like
  0103e                                                 G\*01:03:01:02                                   UTR-13                                             HG0103                                             0.00558            G0103e/G\*01:03:01:02/UTR-13
  010102a                                               Unknown/new                                      UTR-2                                              HG010102                                           0.00558            G010102a/unknown/UTR-2
  010101a                                               G\*01:01:09                                      UTR-4                                              HG010101\*                                         0.00558            G010101a/G\*01:01:09/UTR-4

*^a^*HLA-G* promoter haplotypes were named according to the previous studies ([@B76], [@B118])*.

^b^*HLA-G* coding haplotypes were converted into coding alleles based on the International Immunogenetics Database (IMGT/HLA). When a haplotype is close to one known haplotype, except for a single nucleotide modification, suffix "-Like" was added. The new HLA-G allele is defined with the suffix "new."

*^c^*HLA-G* 3′ untranslated haplotypes were named according to the previous studies ([@B69], [@B76], [@B88], [@B110])*.

*^d^*HLA-G* lineages were named according to a previous study ([@B76])*.

*^e^Names proposed for the *HLA-G* extended haplotypes*.

\*Denotes possible crossing overs among known lineages

*Haplotypes are ordered according to their global frequency*.

The extended haplotypes shown in Table [11](#T11){ref-type="table"} were classified according to previously defined *HLA-G* lineages ([@B76], [@B118]). It becomes clear that most of the extended haplotypes are associated with the same encoded full-length molecule and functional polymorphisms are mainly present at the regulatory regions. In fact, many polymorphisms in the regulatory regions do present high frequencies (around 50%), what is compatible with the evidence of balancing selection acting on the *HLA-G* regulatory regions ([@B3], [@B69], [@B76], [@B88], [@B115], [@B118], [@B121]). For example, lineages HG010101 (a, b or c) and HG010102 are associated with *HLA-G* coding alleles that usually encode the same HLA-G molecules (exception made to the G\*01:06 and G\*01:05N alleles), but the promoter and 3′UTR haplotypes are the most divergent ones compared to each other.

Recently, the Neanderthal genome sequence corresponding to a sample dating 40,000 years was published ([@B122]). The same pipeline described above was applied to this Neanderthal genome and we found that this unique sample does present a *HLA-G* haplotype found among modern humans with a frequency of 0.00604 (G010101f/G\*01:01:01:04/UTR-6) and another haplotype that was not found in the present series and is composed of a recombined promoter, an unknown *HLA-G* coding allele close to G\*01:01:02:01 and UTR-2.

*HLA-G* Worldwide Diversity {#S8}
===========================

Human leukocyte antigen G worldwide intrapopulational genetic diversity was evaluated by means of different population genetics parameters (Table [12](#T12){ref-type="table"}). Except for the number of private alleles, which is greatly influenced by sample sizes and the number of different samples from a same geographic area (group), African populations exhibited higher levels of genetic diversity in comparison with Europeans and Asians. Admixed populations sampled in America also revealed high levels of diversity. These findings are consistent with the current knowledge that older and admixed populations are prone to exhibit larger diversity than younger and non-admixed populations. Similar observations are made when the promoter (Table [13](#T13){ref-type="table"}) and coding (Table [14](#T14){ref-type="table"}) regions are considered separately. Since these differences between Africans and non-Africans are not as substantial as those observed for neutral markers ([@B123]), such similar levels of diversity may be reflecting both demographic events and the action of balancing selection. However, when the 3′UTR is considered (Table [15](#T15){ref-type="table"}), a different pattern arises, regarding gene and nucleotide diversity. For instance, Europeans present the highest levels while Africans presents the lowest levels. This finding does not present a straightforward explanation, although one may suppose that a stronger signature of balancing selection over *HLA-G* 3′UTR may have distorted demographic signatures, resulting in a higher diversity in Eurasia. It should be emphasized that, as previously reported for a Brazilian population sample ([@B76]) and also for the populations of the 1000Genomes Project ([@B69]), both the promoter and 3′UTR diversity have been shaped by a strong balancing pressure.

###### 

**Genetic diversity parameters and probability of adherence of diplotype frequencies to Hardy--Weinberg equilibrium expectations (*p*HWE), considering whole *HLA-G* ha.plotypes**.

  Population sample      Gene diversity    Private haplotypes   Haplotype diversity   Nucleotide diversity (%)   *p*HWE
  ---------------------- ----------------- -------------------- --------------------- -------------------------- -----------------
  Africa (2*n* = 362)    0.2913 ± 0.1949   36                   0.9417 ± 0.0054       0.7643 ± 0.3690            0.6582 ± 0.0137
   LWK (2*n* = 188)      0.3108 ± 0.1888   24                   0.9497 ± 0.0075       0.7815 ± 0.3781            0.7200 ± 0.0130
   YRI (2*n* = 174)      0.3175 ± 0.1722   10                   0.9118 ± 0.0121       0.7283 ± 0.3531            0.5892 ± 0.0134
  Europe (2*n* = 752)    0.2663 ± 0.2162   33                   0.8622 ± 0.0088       0.7399 ± 0.3570            0.8219 ± 0.0113
   CEU (2*n* = 170)      0.3315 ± 0.1902   6                    0.8210 ± 0.0231       0.7384 ± 0.3579            0.5821 ± 0.0133
   FIN (2*n* = 184)      0.2940 ± 0.1828   17                   0.8501 ± 0.0187       0.6679 ± 0.3243            0.4973 ± 0.0142
   GBR (2*n* = 174)      0.3234 ± 0.2036   8                    0.8679 ± 0.0168       0.7632 ± 0.3696            0.3129 ± 0.0126
   IBS (2*n* = 28)       0.4330 ± 0.1566   0                    0.8492 ± 0.0412       0.7737 ± 0.3867            0.6021 ± 0.0065
   TSI (2*n* = 196)      0.3055 ± 0.2078   9                    0.8883 ± 0.0141       0.7546 ± 0.3653            0.7044 ± 0.0125
  Asia (2*n* = 570)      0.2675 ± 0.2013   41                   0.8503 ± 0.0090       0.6782 ± 0.3280            0.6628 ± 0.0137
   CHB (2*n* = 192)      0.3185 ± 0.1816   5                    0.8560 ± 0.0141       0.7093 ± 0.3439            0.3700 ± 0.0131
   CHS (2*n* = 200)      0.3362 ± 0.1953   19                   0.8141 ± 0.0204       0.6898 ± 0.3345            0.6625 ± 0.0134
   JPT (2*n* = 178)      0.2710 ± 0.1617   4                    0.8468 ± 0.0141       0.5857 ± 0.2854            0.5297 ± 0.0136
  Admixed (2*n* = 468)   0.2908 ± 0.1999   26                   0.9332 ± 0.0059       0.7890 ± 0.3805            0.6699 ± 0.0136
   ASW (2*n* = 118)      0.3253 ± 0.1908   6                    0.9483 ± 0.0092       0.8108 ± 0.3933            0.7233 ± 0.0130
   CLM (2*n* = 116)      0.3337 ± 0.1786   8                    0.9237 ± 0.0113       0.7655 ± 0.3718            0.3765 ± 0.0131
   MXL (2*n* = 124)      0.3508 ± 0.1774   3                    0.9110 ± 0.0146       0.8045 ± 0.3902            0.6571 ± 0.0129
   PUR (2*n* = 110)      0.3220 ± 0.1687   7                    0.9296 ± 0.0140       0.7599 ± 0.3693            0.3774 ± 0.0134
  Total (2*n* = 2152)    0.2345 ± 0.2149   \-                   0.9068 ± 0.0040       0.7548 ± 0.3637            0.9025 ± 0.0089

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

###### 

**Genetic diversity parameters and probability of adherence of diplotype frequencies to Hardy--Weinberg equilibrium expectations (*p*HWE), considering *HLA-G* promoter haplotypes**.

  Population sample      Gene diversity    Private haplotypes   Haplotype diversity   Nucleotide diversity (%)   *p*HWE
  ---------------------- ----------------- -------------------- --------------------- -------------------------- -----------------
  Africa (2*n* = 362)    0.2908 ± 0.2034   7                    0.8438 ± 0.0092       0.6604 ± 0.3380            0.4466 ± 0.0127
   LWK (2*n* = 188)      0.3000 ± 0.1941   5                    0.8397 ± 0.0147       0.6590 ± 0.3382            0.7370 ± 0.0110
   YRI (2*n* = 174)      0.3154 ± 0.1907   1                    0.8269 ± 0.0149       0.6447 ± 0.3315            0.0849 ± 0.0051
  Europe (2*n* = 752)    0.2401 ± 0.2252   14                   0.7725 ± 0.0091       0.5998 ± 0.3088            0.5186 ± 0.0138
   CEU (2*n* = 170)      0.2818 ± 0.2120   1                    0.7471 ± 0.0217       0.5972 ± 0.3090            0.9768 ± 0.0026
   FIN (2*n* = 184)      0.2584 ± 0.2054   7                    0.7899 ± 0.0164       0.5476 ± 0.2852            0.2223 ± 0.0107
   GBR (2*n* = 174)      0.2970 ± 0.2193   1                    0.7379 ± 0.0216       0.6069 ± 0.3135            0.0324 ± 0.0036
   IBS (2*n* = 28)       0.4400 ± 0.1504   0                    0.7169 ± 0.0559       0.6000 ± 0.3202            0.6445 ± 0.0027
   TSI (2*n* = 196)      0.2723 ± 0.2249   4                    0.7848 ± 0.0176       0.6183 ± 0.3188            0.3980 ± 0.0125
  Asia (2*n* = 570)      0.2517 ± 0.2189   8                    0.7536 ± 0.0076       0.5524 ± 0.2864            0.5938 ± 0.0129
   CHB (2*n* = 192)      0.2878 ± 0.2038   1                    0.7627 ± 0.0155       0.5664 ± 0.2941            0.6127 ± 0.0108
   CHS (2*n* = 200)      0.3403 ± 0.2187   3                    0.7166 ± 0.0183       0.5672 ± 0.2944            0.5743 ± 0.0112
   JPT (2*n* = 178)      0.2574 ± 0.1806   1                    0.7409 ± 0.0171       0.4871 ± 0.2564            0.3093 ± 0.0104
  Admixed (2*n* = 468)   0.2927 ± 0.1958   9                    0.8700 ± 0.0081       0.6868 ± 0.3502            0.3354 ± 0.0122
   ASW (2*n* = 118)      0.3128 ± 0.1907   1                    0.8573 ± 0.0189       0.6867 ± 0.3525            0.3945 ± 0.0122
   CLM (2*n* = 116)      0.3136 ± 0.1923   2                    0.8777 ± 0.0147       0.6884 ± 0.3533            0.3855 ± 0.0108
   MXL (2*n* = 124)      0.3241 ± 0.1851   0                    0.8432 ± 0.0185       0.6870 ± 0.3525            0.5318 ± 0.0100
   PUR (2*n* = 110)      0.3097 ± 0.1790   4                    0.8881 ± 0.0142       0.6798 ± 0.3494            0.7863 ± 0.0092
  Total (2*n* = 2152)    0.2323 ± 0.2208   --                   0.8145 ± 0.0047       0.6331 ± 0.3243            0.4803 ± 0.0142

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

###### 

**Genetic diversity parameters and probability of adherence of diplotype frequencies to Hardy--Weinberg equilibrium expectations (*p*HWE), considering *HLA-G* coding region haplotypes**.

  Population sample      Gene diversity    Private haplotypes   Haplotype diversity   Nucleotide diversity (%)   *p*HWE
  ---------------------- ----------------- -------------------- --------------------- -------------------------- -----------------
  Africa (2*n* = 362)    0.2983 ± 0.2036   14                   0.9177 ± 0.0053       0.6649 ± 0.3266            0.6983 ± 0.0122
   LWK (2*n* = 188)      0.3100 ± 0.1981   9                    0.9255 ± 0.0077       0.6691 ± 0.3295            0.6843 ± 0.0121
   YRI (2*n* = 174)      0.3306 ± 0.1808   4                    0.8934 ± 0.0116       0.6436 ± 0.3175            0.6841 ± 0.0110
  Europe (2*n* = 752)    0.2588 ± 0.2233   15                   0.8292 ± 0.0085       0.6229 ± 0.3063            0.6674 ± 0.0132
   CEU (2*n* = 170)      0.3348 ± 0.1930   2                    0.7908 ± 0.0221       0.6162 ± 0.3045            0.5567 ± 0.0117
   FIN (2*n* = 184)      0.3019 ± 0.1893   8                    0.8011 ± 0.0192       0.5665 ± 0.2808            0.5260 ± 0.0133
   GBR (2*n* = 174)      0.3151 ± 0.2112   4                    0.8449 ± 0.0163       0.6358 ± 0.3138            0.1818 ± 0.0096
   IBS (2*n* = 28)       0.4308 ± 0.1625   0                    0.8492 ± 0.0412       0.6405 ± 0.3262            0.5893 ± 0.0067
   TSI (2*n* = 196)      0.3070 ± 0.2151   0                    0.8563 ± 0.0136       0.6411 ± 0.3161            0.9138 ± 0.0062
  Asia (2*n* = 570)      0.2631 ± 0.2097   13                   0.7914 ± 0.0095       0.5772 ± 0.2848            0.4079 ± 0.0135
   CHB (2*n* = 192)      0.3089 ± 0.1866   2                    0.8106 ± 0.0144       0.5903 ± 0.2920            0.3012 ± 0.0107
   CHS (2*n* = 200)      0.3567 ± 0.2013   8                    0.7495 ± 0.0187       0.5934 ± 0.2934            0.4342 ± 0.0131
   JPT (2*n* = 178)      0.2649 ± 0.1712   1                    0.7645 ± 0.0188       0.4969 ± 0.2478            0.3456 ± 0.0110
  Admixed (2*n* = 468)   0.2834 ± 0.2095   14                   0.8970 ± 0.0060       0.6621 ± 0.3251            0.4418 ± 0.0136
   ASW (2*n* = 118)      0.3200 ± 0.1953   3                    0.9126 ± 0.0107       0.6796 ± 0.3355            0.4556 ± 0.0131
   CLM (2*n* = 116)      0.3335 ± 0.1958   5                    0.8888 ± 0.0127       0.6494 ± 0.3212            0.2857 ± 0.0113
   MXL (2*n* = 124)      0.3482 ± 0.1815   2                    0.8624 ± 0.0149       0.6655 ± 0.3287            0.9311 ± 0.0048
   PUR (2*n* = 110)      0.3264 ± 0.1823   3                    0.8992 ± 0.0138       0.6471 ± 0.3202            0.5820 ± 0.0123
  Total (2*n* = 2152)    0.2244 ± 0.2219   --                   0.8780 ± 0.0038       0.6432 ± 0.3156            0.5692 ± 0.0143

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

###### 

**Genetic diversity parameters and probability of adherence of diplotype frequencies to Hardy--Weinberg equilibrium expectations (*p*HWE), considering *HLA-G* 3′UTR haplotypes**.

  Population sample      Gene diversity    Private haplotypes   Haplotype diversity   Nucleotide diversity (%)   *p*HWE
  ---------------------- ----------------- -------------------- --------------------- -------------------------- -----------------
  Africa (2*n* = 362)    0.2833 ± 0.1700   8                    0.8583 ± 0.0073       2.6744 ± 1.3827            0.1986 ± 0.0098
   LWK (2*n* = 188)      0.3326 ± 0.1626   5                    0.8573 ± 0.0124       2.9077 ± 1.4972            0.5067 ± 0.0116
   YRI (2*n* = 174)      0.2965 ± 0.1268   3                    0.8350 ± 0.0143       2.3841 ± 1.2486            0.6058 ± 0.0091
  Europe (2*n* = 752)    0.3276 ± 0.1795   5                    0.7885 ± 0.0084       2.9784 ± 1.5247            0.5801 ± 0.0127
   CEU (2*n* = 170)      0.3938 ± 0.1332   0                    0.7577 ± 0.0203       3.0292 ± 1.5558            0.8857 ± 0.0057
   FIN (2*n* = 184)      0.3258 ± 0.1294   1                    0.7612 ± 0.0173       2.6197 ± 1.3603            0.9146 ± 0.0043
   GBR (2*n* = 174)      0.3802 ± 0.1585   1                    0.7986 ± 0.0189       3.1900 ± 1.6321            0.0704 ± 0.0059
   IBS (2*n* = 28)       0.4352 ± 0.1545   0                    0.7460 ± 0.0537       3.3476 ± 1.7617            0.8526 ± 0.0025
   TSI (2*n* = 196)      0.3515 ± 0.1613   1                    0.8158 ± 0.0141       2.9499 ± 1.5169            0.5941 ± 0.0105
  Asia (2*n* = 570)      0.3045 ± 0.1569   5                    0.7507 ± 0.0098       2.6613 ± 1.3750            0.1824 ± 0.0093
   CHB (2*n* = 192)      0.3849 ± 0.1194   0                    0.7920 ± 0.0133       2.9605 ± 1.5222            0.3045 ± 0.0084
   CHS (2*n* = 200)      0.3006 ± 0.1598   5                    0.7234 ± 0.0198       2.6274 ± 1.3634            0.3031 ± 0.0104
   JPT (2*n* = 178)      0.3086 ± 0.1024   0                    0.6681 ± 0.0253       2.2658 ± 1.1920            0.6259 ± 0.0076
  Admixed (2*n* = 468)   0.3147 ± 0.1855   1                    0.8385 ± 0.0077       2.9705 ± 1.5222            0.3325 ± 0.0117
   ASW (2*n* = 118)      0.3598 ± 0.1835   0                    0.8415 ± 0.0172       3.1446 ± 1.6150            0.2936 ± 0.0101
   CLM (2*n* = 116)      0.3702 ± 0.0917   0                    0.8273 ± 0.0139       2.7185 ± 1.4119            0.9862 ± 0.0011
   MXL (2*n* = 124)      0.3958 ± 0.1545   1                    0.8270 ± 0.0178       3.1832 ± 1.6327            0.9469 ± 0.0039
   PUR (2*n* = 110)      0.3338 ± 0.1180   0                    0.8459 ± 0.0184       2.6841 ± 1.3962            0.0933 ± 0.0045
  Total (2*n* = 2152)    0.2730 ± 0.1921   --                   0.8223 ± 0.0041       2.8640 ± 1.4692            0.2546 ± 0.0118

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

The comparison of the three different *HLA-G* regions (Tables [13](#T13){ref-type="table"}--[15](#T15){ref-type="table"}) also reveals interesting aspects. The average expected heterozygosity (gene diversity) for variation sites at the 3′UTR is \~20% higher (0.2730) than the estimated ones for the promoter (0.2323) and coding (0.2244) regions. As a consequence, nucleotide diversity is 4.5 times higher for the 3′UTR (2.8640%) than for the promoter (0.6331%) and coding (0.6432%) regions. Nucleotide diversity at *HLA-G* 3′UTR is almost 40 times higher than the human genome average (0.075%) ([@B118], [@B124]), resulting in an astonishing average of 8.19 differences when two randomly chosen 3′UTR (286-bp long) haplotypes are compared. Balancing selection favors the maintenance of different alleles in a population, resulting in a proportionally higher average pair-wise difference as compared with the measure of diversity based on the number of polymorphic sites. The worldwide nucleotide diversity at the whole *HLA-G* locus (0.7548%) is as expected slightly higher than that observed for the Brazilian population sample (0.00643%) ([@B76]). The direct comparison of haplotype diversity between the three regions could not be performed, since the very different lengths and number of variation sites of the three regions (Tables [2](#T2){ref-type="table"}, [5](#T5){ref-type="table"}, and [8](#T8){ref-type="table"}) may bias any retrieved conclusions.

Two independent approaches were used to evaluate the extent of differentiation between pairs of populations (interpopulation diversity): *F~ST~* and the exact test of population differentiation based on haplotype frequencies. Although these analyses have the same purpose and may provide similar results, both were performed to provide more reliable and robust conclusions. The analysis of the pair-wise *F~ST~* matrix revealed a large range of variation of *F~ST~* values: from −0.0150, between British from England and Scotland (GBR) and Iberian populations from Spain (IBS), to 0.2037, between Finnish (FIN) and Japanese (JPT) (Table [16](#T16){ref-type="table"}). While only 1 out of 6 (16.7%) pairs of admixed populations and 4 out of 10 (40%) European populations differed significantly at the 5% unadjusted significance level; it is noteworthy that the two African populations, as well as the three Asian populations, differed. IBS presented the lowest number of significant comparisons (2 out of 13), a fact that is clearly related to the lack of statistical power due to the small sample size. On the other hand, JPT (all comparisons), CHB (12 out of 13), CHS (12 out of 13), FIN (12 out of 13), and YRI (11 out of 13) presented the largest number of significant comparisons. An overall stronger differentiation was observed by the matrix composed of non-differentiation probability values obtained through the exact test of population differentiation (Table [17](#T17){ref-type="table"}). While only 3 out of 10 (30%) European populations differed significantly at the 5% significance level, it is noteworthy that the two African populations, as well as the three Asian populations and four admixed populations, differed. IBS presented the lowest number of significant comparisons (4 out of 13), while JPT, CHB, CHS and YRI differed in all pair-wise comparisons including them. To sum up, both the exact test of population differentiation based on haplotype frequencies and the *F~ST~* estimate revealed the existence of highly significant difference between the 14 populations. Since the more frequent *HLA-G* haplotypes are shared between most of the populations, these pair-wise population differences may be due to the existence of many low-frequency haplotypes that are restricted to two or three populations (22.5% of the 200 identified haplotypes) or are private to a single population (63% of the 200 haplotypes).

###### 

**Matrix of pair-wise *F~ST~* values based on whole *HLA-G* haplotype frequencies (below the diagonal) and probabilities associated with pair-wise *F~ST~* values (above the diagonal) for the 14 populations analyzed in the present study**.

        CEU              TSI              GBR              FIN              IBS            CHB              JPT              CHS              YRI              LWK              ASW              MXL              PUR              CLM
  ----- ---------------- ---------------- ---------------- ---------------- -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  CEU                    **0.0360**       0.3423           0.1081           0.3604         ***0.0000\****   ***0.0000\****   ***0.0090***     ***0.0000\****   0.0901           **0.0180**       0.0541           0.1892           **0.0451**
  TSI   **0.0086**                        0.3694           ***0.0000\****   0.6396         **0.0180**       ***0.0000\****   **0.0180**       **0.0180**       0.2342           0.1532           0.3063           **0.0451**       0.4775
  GBR   0.0005           −0.0012                           ***0.0090***     0.8288         ***0.0000\****   ***0.0000\****   ***0.0090***     ***0.0000\****   0.1441           **0.0360**       0.2342           0.0541           0.1171
  FIN   0.0083           ***0.0391\****   ***0.0288***                      **0.0270**     ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   **0.0180**       ***0.0000\****
  IBS   −0.0018          −0.0123          −0.0150          **0.0411**                      0.1261           ***0.0090***     0.0991           0.0721           0.3514           0.5135           0.6577           0.1441           0.3694
  CHB   ***0.0679\****   **0.0251**       ***0.0385\****   ***0.1219\****   0.0246                          **0.0270**       **0.0180**       ***0.0090***     ***0.0000\****   **0.0270**       ***0.0000\****   ***0.0000\****   **0.0270**
  JPT   ***0.1434\****   ***0.0772\****   ***0.1067\****   ***0.2037\****   ***0.0981***   **0.0203**                        ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****
  CHS   ***0.0366***     **0.0179**       ***0.0233***     ***0.0707\****   0.0249         **0.0152**       ***0.0610\****                    ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   **0.0180**
  YRI   ***0.0562\****   **0.0174**       ***0.0365\****   ***0.0940\****   0.0270         ***0.0182***     ***0.0362\****   ***0.0317\****                    ***0.0000\****   **0.0360**       ***0.0090***     ***0.0000\****   0.1712
  LWK   0.0070           0.0028           0.0037           ***0.0294\****   −0.0020        ***0.0469\****   ***0.1041\****   ***0.0331\****   ***0.0221\****                    0.1532           0.1622           0.2883           0.3153
  ASW   **0.0237**       0.0044           **0.0087**       ***0.0659\****   −0.0056        **0.0252**       ***0.0767\****   ***0.0344\****   **0.0130**       0.0035                            0.7748           **0.0270**       0.2883
  MXL   0.0142           0.0006           0.0021           ***0.0535\****   −0.0101        ***0.0236\****   ***0.0810\****   ***0.0256\****   ***0.0191***     0.0029           −0.0057                           0.0541           0.3423
  PUR   0.0053           **0.0128**       0.0111           **0.0151**       0.0178         ***0.0625\****   ***0.1287\****   ***0.0311\****   ***0.0369\****   0.0027           **0.0183**       0.0128                            0.1982
  CLM   **0.0164**       −0.0011          0.0074           ***0.0450\****   0.0005         **0.0235**       ***0.0671\****   **0.0180**       0.0054           0.0009           0.0015           0.0000           0.0055           

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

*Statistically significant *F~ST~* values are in boldface (*p* \< 0.05) or italicized boldface (*p* \< 0.01)*. *Statistically significant values at a 5% significance level after Bonferroni correction are marked with an asterisk (p \< 0.0005)*.

###### 

**Matrix of non-differentiation probabilities obtained by means of exact tests of population differentiation based on haplotype frequencies for the 14 populations analyzed in the present study**.

        CEU              TSI              GBR              FIN              IBS              CHB              JPT              CHS              YRI              LWK              ASW              MXL          PUR          CLM
  ----- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ------------ ------------ -----
  CEU                                                                                                                                                                                                                        
  TSI   0.2109                                                                                                                                                                                                               
  GBR   0.1051           0.0765                                                                                                                                                                                              
  FIN   ***0.0062***     ***0.0004\****   ***0.0000\****                                                                                                                                                                     
  IBS   0.6345           0.9226           0.9772           0.2932                                                                                                                                                            
  CHB   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0057***                                                                                                                                     
  JPT   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0002\****   ***0.0000\****                                                                                                                  
  CHS   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0001\****   **0.0105**       ***0.0000\****                                                                                                 
  YRI   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****                                                                                
  LWK   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   0.3488           ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****                                                               
  ASW   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   0.3020           ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   0.1072                                                      
  MXL   ***0.0000\****   ***0.0004\****   ***0.0000\****   ***0.0000\****   0.4085           ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0004\****                             
  PUR   ***0.0001\****   **0.0048**       ***0.0006***     ***0.0000\****   0.7816           ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   0.0677                    
  CLM   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   0.5290           ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0000\****   ***0.0001\****   **0.0437**   **0.0117**   

*CEU, Utah residents with Northern and Western European ancestry; TSI, Toscani from Italy; GBR, British from England and Scotland; FIN, Finnish from Finland; IBS, Iberian populations from Spain; CHB, Han Chinese from Beijing; CHS, Han Chinese from South China; JPT, Japanese from Tokyo, Japan; YRI, Yoruba from Ibadan, Nigeria; LWK, Luhya from Webuye, Kenya; ASW, people of African ancestry from the southwestern United States; MXL, people of Mexican ancestry from Los Angeles, California; PUR, Puerto Ricans from Puerto Rico; CLM, Colombians from Medellin, Colombia*.

*Statistically significant *F~ST~* values are in boldface (*p* \< 0.05) or italicized boldface (*p* \< 0.01)*. *Statistically significant values at a 5% significance level after Bonferroni correction are marked with an asterisk (p \< 0.0005)*.

To further explore the genetic relationships between populations, an AMOVA was performed assuming a hierarchical structure in which the 14 populations were divided into four groups: African, Asian, European, and admixed populations (Table [18](#T18){ref-type="table"}). Considering the whole *HLA-G* gene, differences between the four groups account for only 2.45% of the variance, whereas 1.64% of the variance occurs as a consequence of differences between populations that belong to a same group. Almost all the variance (95.91%) is observed within populations. This same pattern is observed when each *HLA-G* region, i.e., promoter, coding, and 3′UTR, is considered separately, with the exception of the 3′UTR where the variance among groups (0.65%) gets even lower than the variance among populations that belong to a same group (1.32%), and is statistically non-significant.

###### 

**Analysis of molecular variance (AMOVA) for *HLA-G* haplotype frequencies, according to two different hierarchical structures and four different *HLA-G* datasets**.

  Groups composing the hierarchical structure [^a^](#tfn1){ref-type="table-fn"}                         HLA-G data type   Variance                                                        
  ----------------------------------------------------------------------------------------------------- ----------------- ------------------------------- ------------------------------- --------------------------------
  Africa: LWK, YRI; Asia: CHB, CHS, JPT; Europe: CEU, FIN, GBR, IBS, TSI; Admixed: ASW, CLM, MXL, PUR   Promoter          3.09% (*p* = 0.0098 ± 0.0033)   1.57% (*p* = 0.0000 ± 0.0000)   95.34% (*p* = 0.0000 ± 0.0000)
                                                                                                        Coding region     2.99% (*p* = 0.0049 ± 0.0020)   1.81% (*p* = 0.0000 ± 0.0000)   95.20% (*p* = 0.0000 ± 0.0000)
                                                                                                        3′UTR             0.65% (*p* = 0.0665 ± 0.0000)   1.32% (*p* = 0.0000 ± 0.0000)   98.02% (*p* = 0.0000 ± 0.0000)
                                                                                                        Whole gene        2.45% (*p* = 0.0029 ± 0.0016)   1.64% (*p* = 0.0000 ± 0.0000)   95.91% (*p* = 0.0000 ± 0.0000)
                                                                                                                                                                                          
  Africa: LWK, YRI; Asia: CHB, CHS, JPT; Europe: CEU, FIN, GBR, IBS, TSI                                Promoter          4.28% (*p* = 0.0156 ± 0.0039)   2.01% (*p* = 0.0000 ± 0.0000)   93.71% (*p* = 0.0000 ± 0.0000)
                                                                                                        Coding region     4.14% (*p* = 0.0147 ± 0.0042)   2.28% (*p* = 0.0000 ± 0.0000)   93.58% (*p* = 0.0000 ± 0.0000)
                                                                                                        3′UTR             1.00% (*p* = 0.0332 ± 0.0065)   1.32% (*p* = 0.0010 ± 0.0010)   97.68% (*p* = 0.0000 ± 0.0000)
                                                                                                        Whole gene        3.42% (*p* = 0.0166 ± 0.0000)   1.99% (*p* = 0.0000 ± 0.0000)   94.59% (*p* = 0.0000 ± 0.0000)

Since the group composed of admixed populations represent an assembly of populations whose individuals present varying levels of ancestry that can be assigned to Africans, Amerindians/Asians, and Europeans, this group was removed from a second round of analysis (Table [18](#T18){ref-type="table"}). As a result, levels of variance between groups increased, although still lower than the expected ones for neutrally evolving sequences ([@B123]). Therefore, one may conclude that this analysis reflects the fact that most of the *HLA-G* diversity, particularly that from the 3′UTR, (a) originated from Africa before *Homo sapiens* dispersion to other continents and (b) has been maintained in worldwide populations by non-neutral evolutionary forces, particularly balancing selection. These conclusions are corroborated by previous data on *HLA-G* ([@B68], [@B69], [@B76], [@B89], [@B121]). Moreover, many different low-frequency haplotypes are being generated within populations by mutation and recombination. These features are responsible for the relatively poor resolution of the MDS plot (Figure [2](#F2){ref-type="fig"}) obtained with the matrix of Reynolds' genetic distance based on the whole *HLA-G* gene. Unexpectedly, (a) populations from a same geographic group, for example Asians (CHB, CHS and JPT), are distributed across large distances in the plot and (b) admixed populations (CLM, MXL, and PUR) that present major European, intermediate Amerindian, and minor African ancestry contributions ([@B66]), as revealed by the analysis of Ancestry Informative Markers (data not shown), are clustered together with African populations. These unexpected findings support the hypothesis that a strong signature of balancing selection over *HLA-G* may have distorted the expected demographic signatures.

![**Multidimensional scaling (MDS) plot revealing the genetics relationships between the 14 populations of the 1000Genomes Project (Phase 1)**.](fimmu-05-00476-g002){#F2}

*HLA-G* Evolution Aspects {#S9}
=========================

The MHC class I molecules evolved by a series of events that include chromosomal duplication, gene recombination, and selection probably driven by pathogens ([@B125]--[@B127]). Apparently, *MHC-G*, the *HLA-G* homologous sequence in non-human primates, is the oldest class I gene and it would be responsible for the origin of the whole class I loci ([@B127]). In fact, MHC class I genes from the New World primates, such as the cotton-top tamarin (*Saguinus oedipus*), are much closer to the human *HLA-G* than other human classical class I genes ([@B127]). This primate lineage separated from the one that gave rise to the Old World monkeys (or anthropoids) about 38 million years ago. It is noteworthy that the HLA-G and MHC-G molecules are functionally different despite the high identity among exonic sequences ([@B128]). New World primates' MHC-G plays a role in antigen presentation that is uncommon for human HLA-G, and this fact suggests that they are not orthologous as theorized in the past ([@B129], [@B130]). In contrast, the cotton-top tamarin presents two MHC-C molecules with inhibitory properties that interact with KIR receptors ([@B131]). The regulation of MHC levels (in this case, MHC-C) in these non-human primates seems to be one of the responsible mechanisms for fetal acceptance as well as for the shorter pregnancy period ([@B132]).

Old World primates have a peculiar MHC-G molecule. It presents just the α1 domain due to a stop codon at codon 164 ([@B133]), which may not hinder fetal protection against maternal NK cells, unless there is a mechanism in which the stop codon is ignored, allowing translation to continue (which is not discarded). In addition, gorillas and chimpanzees present a conserved *MHC-G* coding segment with few variations ([@B3], [@B128], [@B129]). Even the pregnancy period being shorter than in human beings, these species are polygamous, which would expose the female to different allogeneic fetuses during the fertile age. Orangutans on the other hand have long-lasting relationships and five *MHC-G* variants have been found so far -- the polymorphism levels are low but more similar to human beings ([@B3]). Orangutans and humans are separated by about 15 million years of evolution. Possibly, the differences between maternal-fetal relationships among different species are responsible for each *MHC-G* peculiarities and for its function and variation levels.

In addition to alignments between human and other primates coding *MHC-G* sequences, analyses of *HLA-G* non-coding regions have proved to be highly informative about the evolutionary history of this gene. For example, the polymorphism of 14-pb located on *HLA-G* exon 8 (3′UTR) is exclusively found in the human lineage, suggesting that UTR haplotypes bearing the deletion such as UTR-1 are more recent than the ones that present the 14-bp fragment ([@B134]).

An interesting finding confirmed recently is that one of the most frequent *HLA-G* coding allele (global frequency of 0.24257), *G\*01:01:01:01*, which is usually associated with UTR-1 and the promoter haplotype G010101a \[described in Ref. ([@B76]) and Table [11](#T11){ref-type="table"}\], is probably the most recent haplotype. These data were established by the association between *G\*01:01:01:01*/UTR-1 with an *Alu* insertion (*AluyHG*) that occurred before human dispersion from Africa, in a location 20 Kb downstream *HLA-G* 3′UTR. The frequency of this Alu element increases with distance from Africa ([@B68]).

Given the HLA-G immunomodulatory properties and the unique tissue expression patterns, *HLA-G* expression levels must be maintained under a fine regulatory control. In addition, the lack of variability found in its coding region and limited number of proteins coded by this gene lead us to believe that this region is under tight evolutionary forces that limit variation. The differences on mammalian pregnancy and species-specific pathogens must be considered when studying the evolution of the immune system molecules.

*HLA-G* Transcription Regulation {#S10}
================================

Most of the studies already performed to understand *HLA-G* regulation considered as the *HLA-G* promoter 200 nucleotides upstream the first translated ATG and within 1.5 Kb upstream the CDS. The *HLA-G* regulation is unique among all class I genes \[reviewed at Ref. ([@B67])\]. Generally, HLA class I genes present two main regulatory modules in the proximal promoter region (within 200 bases upstream the CDS) that includes \[reviewed at Ref. ([@B67])\] (a) the Enhancer-A (EnhA) that interacts with NF-κB family of transcription factors, which are important elements to induce HLA class I genes expression ([@B135]); (b) the interferon-stimulated response element (ISRE) that consists of a target site for interferon regulatory factors (IRF), which might act as class I activators (IRF-1) or inhibitors (IRF-2 and IRF-8) ([@B135]). The ISRE module is located adjacent to the EnhA element, and both work cooperatively controlling HLA class I genes expression; (c) the SXY module in which the transcription apparatus is mounted.

However, the *HLA-G* gene presents regulation peculiarities that differ from other class I genes \[reviewed at Ref. ([@B67])\]. First, the *HLA-G* EnhA is the most divergent one among the class I genes and is unresponsive to NF-κB ([@B136]) and might only interact with p50 homodimers, which are not potent HLA class I gene transactivators ([@B137]). In addition, the *HLA-G* ISRE is also unresponsive to IFN-γ ([@B138]) due to modified ISRE. In fact, the *HLA-G* locus presents the most divergent ISRE sequence among the class I genes ([@B135], [@B136]), what could explain the absence of IFN-γ induced transactivation. The ISRE is also a target for other protein complexes that may mediate HLA class I transactivation. However, both *HLA-G* EnhA and ISRE seem to bind only the expressed factor Sp1, which apparently does not modulate the constitutive or IFN-induced transactivation of *HLA-G* ([@B136]). Some polymorphisms in promoter region, such as −725 C \> G/T, are close to known regulatory elements. In this matter, the −725 G allele was related with higher *HLA-G* expression levels ([@B120]).

The SXY module comprises the S, X1, X2, and Y boxes and is an important target for regulatory binding elements and HLA class I genes transactivation. Box X1 is a target for the multiprotein complex regulatory factor X (RFX), including RFX5, RFX-associated protein, and RFXANK ([@B137], [@B139]--[@B141]). The RFX members use to interact with an important element for HLA class II transactivation (CIITA), also important to HLA class I gene transactivation ([@B139]). The X2 box is a binding target for activating transcription factor/cAMP response element binding protein (ATF/CREB) transcription factor family ([@B142]) and Y box is a binding target for nuclear factor Y (NFY), which includes subunits alpha, beta, and gamma (NFYA, BFYB, and NFYC) ([@B67], [@B139]). For *HLA-G*, the SXY module presents sequences compatible only with S and X1 elements, but divergent from X2 and Y. Because CIITA is dependent of a functional SXY module, which includes X2 and Y elements, the SXY module does not transactivate *HLA-G* gene ([@B139], [@B143]--[@B146]).

Other regulatory elements within the *HLA-G* promoter have been described, such as heat shock element, located at −469/−454 position, that bind with heat shock factor-1 (HSF-1), important elements involved in immune responses modulation ([@B147]), and progesterone, which is a steroid hormone secreted from corpus luteum and placenta, involved with endometrium maintenance and embryo implantation \[reviewed at Ref. ([@B67])\]. The mechanism involved in HLA-G expression induced by progesterone is primarily mediated by the activation of progesterone receptor and a subsequent binding to a progesterone response element, found in the promoter region ([@B148]). The transactivation of *HLA-G* transcription has also been demonstrated by leukemia inhibitory factor (LIF) ([@B149]) and methotrexate cell exposure ([@B150]). In addition, it was demonstrated an increased *HLA-G* transcription level in choriocarcinoma cell JEG3 line after the treatment with LIF. Furthermore, LIF induces HLA-G expression in the presence of endoplasmic reticulum aminopeptidase-1 (ERAP1), expressed in the endoplasmic reticulum, and repression of ERAP1 culminates in *HLA-G* downregulation, indicating that ERAP1 has an important role in HLA-G regulation ([@B151]). Finally, it is necessary to highlight the importance of methylation status of the *HLA-G* promoter, since it appears to be very important for *HLA-G* transcription ([@B152], [@B153]).

Although some *HLA-G* regulatory elements are known, it is not clear why balancing selection is maintaining divergent lineages since most of the polymorphisms would not theoretically influence *HLA-G* transcription by the known mechanisms, mainly because they do not coincide with known regulatory elements \[reviewed at Ref. ([@B67])\]. It should be noted that the same SNVs described for the *HLA-G* promoter in other manuscripts are also found in the present analysis.

*HLA-G* Post-Transcriptional Regulation {#S11}
=======================================

*HLA-G* might also be regulated by post-transcriptional mechanisms such as alternative splicing and microRNAs. Several studies have reported polymorphisms influencing splicing, mRNA stability, and also the ability of some microRNAs to bind to the *HLA-G* mRNA. The *HLA-G* 3′UTR segment is a key feature for its regulation mainly by the binding of microRNAs and influencing mRNA stability. *HLA-G* 3′UTR presents several polymorphic sites that influence gene expression \[reviewed at Ref. ([@B67])\].

The 14-bp presence or absence (insertion or deletion) polymorphism was implicated in the *HLA-G* transcriptional levels and mRNA stability. The presence of the 14 bases segment in trophoblast samples has been associated with lower mRNA production for most membrane-bound and soluble isoforms ([@B98], [@B154]), and the absence of this segment seems to stabilize mRNA with a consequent higher HLA-G expression ([@B98], [@B155], [@B156]). In addition, *HLA-G* transcripts presenting the 14 bases segment can be further processed with the removal of 92 bases from the complete mRNA ([@B98]), giving rise to a shorter *HLA-G* transcript reported to be more stable than the complete isoform ([@B157]). The alternative splicing associated with the presence of the 14 bases segment is probably driven by other polymorphic sites in Linkage Disequilibrium with this polymorphic site ([@B3]).

The SNP located at position +3142 has been associated with differential HLA-G expression, because it might influence microRNA binding ([@B158]). The presence of a Guanine at the + 3142 is associated with a stronger binding of specific microRNAs, such as miR-148a, miR-148b, and miR-152, decreasing HLA-G expression by mRNA degradation and translation suppression ([@B3], [@B158], [@B159]). In addition, the 14-bp region might also be a target for specific microRNAs and other 3′UTR polymorphisms might also influence microRNA binding ([@B159]). Another polymorphic site that would influence HLA-G expression is located at +3187. The allele +3187A is associated with decreased HLA-G expression because it extends an AU-rich motif that mediates mRNA degradation ([@B106]).

UTR-1 (Table [6](#T6){ref-type="table"}) is the only frequent 3′UTR haplotype that do not carry the 14-bp sequence, and both the high expression alleles +3142G and +3187A. Therefore, it was postulated that this haplotype would be associated with high HLA-G expression; this was confirmed by another study evaluating soluble HLA-G levels and 3′UTR haplotypes ([@B109]). In addition, as already introduced, this haplotype (together with the coding allele *G\*01:01:01:01*) is probably the most recent one ([@B109]) and its frequency might be increased worldwide due to its high-expressing feature.

Concluding Remarks {#S12}
==================

Due to the key features of HLA-G on the regulation of immune response and immune modulation, particularly during pregnancy, the overall structure of the HLA-G molecule has been maintained during the evolution process. This is evident when the variability of more than a thousand individuals is taking into account, and only few encoded different molecules are frequently found. Most of the variation sites found in the *HLA-G* coding region are either synonymous or intronic mutations. The *HLA-G* promoter region presents numerous polymorphic sites, with several examples of variation sites in which both alleles are equally represented. Although the mechanisms underlying why some divergent promoter haplotypes are preferentially selected are still unclear, just a few divergent and frequent promoter haplotypes are found worldwide. The *HLA-G* 3′UTR variability is quite expressive considering the fact that most of the SNVs are true polymorphisms, they are equally represented, and this segment is of short size. These observations, for both promoter and 3′UTR, are compatible with the evidences of balancing selection acting on these regions. Finally, the population comparisons confirmed that most of the *HLA-G* variability has arisen before human dispersion from Africa and that the allele and haplotype frequencies might have been shaped by strong selective pressures.
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